Adverse effects, not elsewhere classified

ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T78 Cause of death: ICD-10 — T78 2 out of 7 registries used, show all original rules.	8934
4. Check minimum number of events None	8934
5. Include endpoints None	8934
6. Filter based on genotype QC (FinnGen only)	8934

Control definitions (FinnGen only)

Control exclude: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T6[6-9]|T7[0-8]
Name in latin: Effectus adversi non alibi classificati

NAME	ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T78
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T78
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Adverse effects, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8934	6336	2598
Unadjusted period prevalence (%)	1.86	2.16	1.15
Median age at first event (years)	46.93	44.47	52.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7985: Matched controls
79851

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XQ800

NOMESCO Finland

Prick test

8.3

323.0

2117

3326

T78.3

ICD-10 Finland

Angioneurotic oedema

335.0

323.0

1794

H02AB06

ATC

prednisolone; systemic

4.5

323.0

5316

24652

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

28.2

323.0

1017

411

C01CA24

ATC

epinephrine; parenteral

25.7

323.0

3395

2236

R06AE07

ATC

cetirizine; oral

3.3

323.0

4977

26510

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

796.9

323.0

1601

X59

ICD-10 Finland

Exposure to unspecified factor

4.0

323.0

2524

8190

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

75.1

323.0

650

T78.4

ICD-10 Finland

Allergy, unspecified

178.4

323.0

5438

942

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.8

323.0

1953

4244

X57

ICD-10 Finland

Unspecified privation

12.0

310.9

593

531

R06AX27

ATC

desloratadine; oral

2.6

309.1

3139

15890

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

7.2

302.3

783

1189

L50.9

ICD-10 Finland

Urticaria, unspecified

6.8

301.8

813

1305

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

976.5

290.2

283

X58

ICD-10 Finland

Exposure to other specified factors

3.3

279.7

1668

5935

R03AC02

ATC

salbutamol; inhalant

2.3

263.5

4835

32156

L50.0

ICD-10 Finland

Allergic urticaria

8.2

261.7

617

807

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.7

253.9

1249

3794

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

221.9

1829

7909

L50.8

ICD-10 Finland

Other urticaria

9.6

220.4

469

513

R06AE09

ATC

levocetirizine; oral

2.7

217.1

1729

7313

W84

ICD-10 Finland

Unspecified threat to breathing

93.6

212.5

236

H02AB07

ATC

prednisone; oral

2.9

205.9

1461

5729

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

194.5

3315

20263

A92

ICPC

Allergy/allergic reaction NOS

5.7

186.9

575

1077

R03DC03

ATC

montelukast; oral

2.5

184.6

1724

7891

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

173.5

3218

20072

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

6.5

172.1

475

773

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.4

171.1

1801

8730

R06.0

ICD-10 Finland

Dyspnoea

2.2

166.3

2066

10826

N02AX02

ATC

tramadol; systemic, rectal

2.0

163.4

3220

20420

A02BC02

ATC

pantoprazole; systemic

1.9

161.0

4962

36955

Z3231

NOMESCO Finland

Registered nurse

2.1

151.2

2350

13469

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.4

143.3

779

2494

R03BA02

ATC

budesonide; inhalant

2.2

140.2

1660

8407

J01FF01

ATC

clindamycin; systemic

2.0

138.4

2289

13350

R06AX22

ATC

ebastine; oral

2.2

135.7

1680

8666

M79.6

ICD-10 Finland

Pain in limb

1.9

133.3

2901

18671

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

133.0

2190

12713

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.1

132.5

311

398

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

194.6

129.0

134

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

127.3

2143

12509

S01GX01

ATC

cromoglicic acid; ophthalmic

2.0

127.3

1954

10997

R06AX13

ATC

loratadine; oral

2.2

126.7

1569

8062

H02AB04

ATC

methylprednisolone; systemic

2.3

123.6

1272

5982

N02BE01

ATC

paracetamol; systemic, rectal

2.0

123.2

6650

57024

R51.80

ICD-10 Finland

Headache

2.2

119.1

1465

7480

E0000UV

ATC

1.8

117.2

3287

22714

J01DB01

ATC

cefalexin; oral

1.9

116.1

6512

55708

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

115.4

1927

11140

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

115.1

3957

29030

R03BA05

ATC

fluticasone; inhalant

2.0

112.3

1650

9056

N03AX16

ATC

pregabalin; oral

2.0

111.0

1832

10517

R60.0

ICD-10 Finland

Localized oedema

2.6

110.5

894

3685

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

110.3

1473

7765

J01AA02

ATC

doxycycline; systemic

1.8

110.2

5852

48551

L20.0

ICD-10 Finland

Besnier prurigo

2.7

109.7

849

3409

R01AD09

ATC

mometasone; nasal

1.7

107.1

3770

27623

XQ802

NOMESCO Finland

Epicutan test

3.5

106.6

534

1593

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

105.3

1150

5527

L27.2

ICD-10 Finland

Dermatitis due to ingested food

8.3

104.6

240

296

R03AC03

ATC

terbutaline; inhalant

2.2

104.0

1267

6400

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

103.7

2014

12219

R01AD08

ATC

fluticasone; nasal

1.8

103.3

2396

15424

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

102.5

1408

7483

Z51.6

ICD-10 Finland

Desensitization to allergens

6.8

102.3

270

411

L50.3

ICD-10 Finland

Dermatographic urticaria

6.2

102.2

288

479

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

102.0

1224

6138

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

29.8

101.7

138

J01FA10

ATC

azithromycin; systemic

1.7

99.1

4884

38930

M54.5

ICD-10 Finland

Low back pain

1.7

96.7

2629

17696

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.6

95.9

258

403

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

9.4

91.8

195

211

J45.1

ICD-10 Finland

Nonallergic asthma

2.8

91.7

661

2533

M25.5

ICD-10 Finland

Pain in joint

1.7

91.7

2279

14871

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

9.7

90.6

190

201

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

90.4

1463

8249

A02BC05

ATC

esomeprazole; systemic

1.7

90.1

2957

20897

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

89.4

3426

25233

J01FA06

ATC

roxithromycin; oral

1.6

88.9

3062

21904

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

88.3

1432

8071

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

88.3

1437

8109

J01DA01

ATC

[U] cefalexin; systemic

1.6

85.9

4780

38573

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

85.0

1680

10141

R02

ICPC

Shortness of breath/dyspnoea

2.2

84.2

963

4693

J01MA02

ATC

ciprofloxacin; systemic

1.7

84.2

2677

18656

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

83.7

1089

5613

J45

ICD-10 Finland

Asthma

2.3

83.6

880

4126

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

82.8

1566

9302

J01MA12

ATC

levofloxacin; systemic

2.0

82.6

1284

7103

R60.9

ICD-10 Finland

Oedema, unspecified

3.4

82.2

428

1312

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

81.6

465

1523

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

80.5

1509

8922

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.3

80.4

433

1361

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

80.1

658

2713

C07AB07

ATC

bisoprolol; oral

1.6

80.0

2837

20286

D07AB08

ATC

desonide; topical

2.2

79.6

919

4490

M03BX02

ATC

tizanidine; oral

1.6

78.6

4696

38130

Z3226

NOMESCO Finland

Physiotherapist

1.9

78.5

1448

8507

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

78.4

2172

14497

E000001

ATC

1.8

78.3

1715

10665

Y96.9

ICD-10 Finland

Unspecified type of accident

5.6

78.3

238

435

P01AB01

ATC

metronidazole; oral, rectal

1.6

78.0

3039

22220

XQ820

NOMESCO Finland

Exposure to medicinal substance

16.5

77.9

127

D07AA02

ATC

hydrocortisone; topical

1.9

77.4

1233

6868

J46

ICD-10 Finland

Status asthmaticus

4.2

76.6

310

767

AA1AD

NOMESCO Finland

CT of head and brain

1.8

75.5

1518

9166

R42

ICD-10 Finland

Dizziness and giddiness

1.8

75.3

1503

9055

T78.9

ICD-10 Finland

Adverse effect, unspecified

159.5

75.1

J01FA09

ATC

clarithromycin; systemic

1.6

75.1

2510

17594

Z71.8

ICD-10 Finland

Other specified counselling

1.7

74.2

1971

12957

X27

ICD-10 Finland

Contact with other specified venomous animals

42.2

73.6

R4110

NOMESCO Finland

Physiotherapy

1.7

73.6

1930

12636

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

73.6

2799

20254

T78.8

ICD-10 Finland

Other adverse effects, not elsewhere classified

725.0

73.3

G44.2

ICD-10 Finland

Tension-type headache

1.9

72.0

1145

6356

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

71.1

2771

20128

R01AD12

ATC

fluticasone furoate; nasal

1.6

70.7

2500

17712

R96

ICPC

Asthma

2.3

70.2

724

3345

D07AC01

ATC

betamethasone; topical

1.6

69.9

2427

17106

N03AX12

ATC

gabapentin; oral

1.9

68.8

1123

6285

ZXE00

NOMESCO Finland

One hour or less

1.5

68.7

3002

22357

C08CA01

ATC

amlodipine; oral

1.6

68.0

2002

13487

N05BA04

ATC

oxazepam; oral

1.7

68.0

1861

12290

D07AC13

ATC

mometasone; topical

1.6

67.8

2112

14446

S06.0

ICD-10 Finland

Concussion

2.1

66.9

855

4348

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

65.8

1833

12142

Z2221

NOMESCO Finland

Medical doctor

1.6

65.8

2161

14964

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

8.6

65.6

146

172

A02BA02

ATC

ranitidine; systemic

1.8

65.4

1301

7789

R03BA01

ATC

beclometasone; inhalant

1.9

64.9

1077

6056

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

64.8

685

3198

R53

ICD-10 Finland

Malaise and fatigue

1.7

64.5

1537

9728

N05BB01

ATC

hydroxyzine; systemic

2.4

64.1

576

2484

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

64.0

887

4659

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

62.5

1018

5679

R74

ICPC

Upper respiratory infection acute

1.6

62.5

2496

18091

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

61.9

1239

7417

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

61.6

675

3203

XQ801

NOMESCO Finland

Intracutantest

13.1

61.5

110

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

61.2

1743

11583

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

59.7

669

3206

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

59.5

1936

13309

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

59.3

996

5612

A02BC01

ATC

omeprazole; systemic

1.6

58.4

1865

12747

L03

ICPC

Low back symptom/complaint

1.6

58.1

1824

12412

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

58.0

1903

13095

R50.9

ICD-10 Finland

Fever, unspecified

1.8

57.8

1072

6246

J02AC01

ATC

fluconazole; systemic

1.5

57.4

3223

25065

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

15.8

57.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

56.7

749

3846

R03BB04

ATC

tiotropium bromide; inhalant

2.2

56.7

601

2806

UJF32

NOMESCO Finland

Coloscopy

1.6

56.2

1635

10887

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

55.9

2517

18634

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

55.8

551

2485

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

55.7

3705

29765

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

55.5

849

4613

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

55.5

1354

8582

L50.1

ICD-10 Finland

Idiopathic urticaria

7.9

55.5

130

167

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

24.1

55.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

55.3

738

3805

J30.3

ICD-10 Finland

Other allergic rhinitis

2.8

55.1

366

1325

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

54.9

951

5407

M79.1

ICD-10 Finland

Myalgia

1.8

54.8

1020

5942

WX002

NOMESCO Finland

Sedation and analgesia

1.7

54.7

1304

8207

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

54.3

910

5109

A02BC03

ATC

lansoprazole; oral

1.6

53.9

1891

13188

N05BA01

ATC

diazepam; systemic, rectal

1.9

53.5

937

5344

WX110

NOMESCO Finland

Local anesthesy

1.5

53.1

5322

46156

WX892

NOMESCO Finland

Monitored bed care

2.3

52.7

536

2451

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

52.5

1592

10692

N06AX21

ATC

duloxetine; oral

1.9

52.5

857

4766

XQ899

NOMESCO Finland

Other assessment of skin

12.1

52.5

N06AX11

ATC

mirtazapine; oral

1.5

52.4

2246

16391

Y34

ICD-10 Finland

Unspecified event, undetermined intent

9.6

52.3

109

115

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

52.3

2238

16325

R03AC13

ATC

formoterol; inhalant

2.6

52.1

398

1567

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

52.0

1047

6249

C03CA01

ATC

furosemide; systemic

1.6

51.9

1406

9160

WQ000

NOMESCO Finland

Hyposensibilisation

7.8

51.6

122

159

M01AE02

ATC

naproxen; oral, rectal

1.4

50.7

4289

35821

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

50.4

643

3250

R05

ICPC

Cough

1.6

49.8

1686

11618

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

49.6

3061

24038

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

49.5

3171

25072

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

49.1

1726

11997

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

49.1

972

5761

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

48.7

2165

15874

R03BA08

ATC

ciclesonide; inhalant

2.0

48.1

637

3267

M01AB05

ATC

diclofenac; systemic, rectal

1.4

48.1

4703

40161

K30

ICD-10 Finland

Functional dyspepsia

1.9

47.9

781

4334

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

47.3

319

1166

R03AC12

ATC

salmeterol; inhalant

2.7

47.0

335

1267

N05CF01

ATC

zopiclone; oral

1.5

46.8

2027

14751

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

46.7

731

3994

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

46.6

861

4984

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

46.5

573

2852

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

46.1

541

2638

N30.0

ICD-10 Finland

Acute cystitis

1.7

46.0

1033

6355

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.9

45.8

156

326

E000002

ATC

1.8

45.8

924

5501

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

45.7

832

4791

N05AH04

ATC

quetiapine; oral

1.6

45.5

1265

8267

D01

ICPC

Abdominal pain/cramps general

1.8

45.4

887

5224

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

45.3

307

1124

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

45.2

319

1199

R11

ICD-10 Finland

Nausea and vomiting

2.0

45.1

614

3183

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

45.1

477

2220

R06AX26

ATC

fexofenadine; oral

2.1

44.7

564

2831

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

44.6

937

5648

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.8

44.5

196

525

J45.8

ICD-10 Finland

Mixed asthma

3.0

44.3

269

919

R01AD05

ATC

budesonide; nasal

2.0

44.2

605

3140

J01MA14

ATC

moxifloxacin; systemic

2.0

43.9

613

3207

R06.4

ICD-10 Finland

Hyperventilation

3.8

43.7

192

513

Y98

ICD-10 Finland

Lifestyle-related condition

15.0

43.6

N06AB04

ATC

citalopram; systemic

1.6

43.6

1510

10418

N06AX16

ATC

venlafaxine; oral

1.7

43.4

1084

6868

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

43.4

1412

9594

L12

ICPC

Hand/finger symptom/complaint

1.7

43.3

1050

6597

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

43.0

5443

48155

G47.3

ICD-10 Finland

Sleep apnoea

1.6

43.0

1271

8429

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

42.9

778

4473

N02AA05

ATC

oxycodone; systemic

1.8

42.8

802

4658

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

42.5

4052

34081

X39

ICD-10 Finland

Exposure to other and unspecified forces of nature

36.2

42.2

R06.2

ICD-10 Finland

Wheezing

2.4

42.1

365

1539

A03

ICPC

Fever

1.6

42.1

1341

9053

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

42.1

302

1147

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

42.1

407

1813

S18

ICPC

Laceration/cut

1.4

42.0

2682

21001

A46

ICD-10 Finland

Erysipelas

1.8

42.0

784

4548

M79.7

ICD-10 Finland

Fibromyalgia

2.6

41.6

310

1204

R21

ICPC

Throat symptom/complaint

1.5

41.5

1747

12576

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

41.4

267

949

R05

ICD-10 Finland

Cough

1.6

41.3

1324

8947

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

41.2

631

3414

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

41.2

1181

7760

M01AH05

ATC

etoricoxib; oral

1.4

40.9

4081

34491

Z00.0

ICD-10 Finland

General medical examination

1.6

40.8

1301

8783

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

40.4

709

4025

J01FA01

ATC

erythromycin; systemic

1.6

40.4

1144

7491

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

40.3

608

3271

ZXD05

NOMESCO Finland

Urgent procedure

1.4

40.1

2190

16610

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

40.1

729

4189

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

40.1

665

3702

R07.3

ICD-10 Finland

Other chest pain

1.9

40.0

627

3423

N06AB10

ATC

escitalopram; oral

1.5

39.8

1565

11087

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

39.7

1858

13658

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

39.5

594

3191

SPAT1254

SPAT

Administration of medicine

1.7

39.5

1003

6374

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

39.4

2171

16485

H01

ICPC

Ear pain/earache

1.7

39.4

885

5430

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

39.4

351

1503

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

39.3

1009

6430

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

39.2

806

4817

R52.9

ICD-10 Finland

Pain, unspecified

1.9

39.1

597

3227

T74.1

ICD-10 Finland

Physical abuse

4.5

39.1

143

323

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

38.8

323

1334

S29

ICPC

Skin symptom/complaint other

1.6

38.0

1135

7522

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

37.9

707

4094

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

37.9

610

3361

C07AA05

ATC

propranolol; systemic

1.5

37.8

1428

10010

L17

ICPC

Foot/toe symptom/complaint

1.5

37.7

1693

12315

R00.2

ICD-10 Finland

Palpitations

2.0

37.7

546

2893

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

37.6

581

3154

N03AX09

ATC

lamotrigine; oral

2.2

37.5

423

2024

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

18.2

37.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

37.3

527

2766

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

37.3

778

4667

J05AB01

ATC

aciclovir; systemic

1.5

37.1

1465

10363

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

37.1

1151

7697

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

37.0

1972

14841

R55

ICD-10 Finland

Syncope and collapse

1.8

37.0

630

3539

A01

ICPC

Pain general/multiple sites

1.9

36.9

536

2842

E000003

ATC

2.3

36.9

364

1638

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.7

36.8

262

991

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

36.6

415

1989

WZC30

NOMESCO Finland

Teaching

1.7

36.6

852

5274

D11

ICPC

Diarrhoea

1.7

36.6

898

5643

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

36.3

425

2067

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

35.9

487

2513

S80.0

ICD-10 Finland

Contusion of knee

2.0

35.8

496

2583

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

35.5

432

2132

J20

ICD-10 Finland

Acute bronchitis

1.8

35.2

664

3855

ZXA00

NOMESCO Finland

Right side

1.5

35.0

1602

11674

J01EA01

ATC

trimethoprim; systemic

1.4

35.0

1755

13028

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

34.7

476

2470

L28

ICPC

Limited function/disability (L)

1.7

34.6

861

5429

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.3

34.4

149

R01AD01

ATC

beclometasone; nasal

1.6

34.3

1077

7209

R07.0

ICD-10 Finland

Pain in throat

1.9

34.3

511

2734

D06

ICPC

Abdominal pain localized other

1.8

34.2

623

3575

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

34.2

835

5237

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

57.4

34.2

L01

ICPC

Neck symptom/complaint

1.6

34.1

977

6397

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

33.9

558

3096

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

33.8

881

5622

N01

ICPC

Headache

1.6

33.8

907

5835

B02AA02

ATC

tranexamic acid; systemic

1.6

33.6

1099

7433

L15

ICPC

Knee symptom/complaint

1.5

33.4

1349

9564

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.3

33.4

325

1452

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

33.4

565

3162

D07AD01

ATC

clobetasol; topical

1.6

33.3

984

6489

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

33.2

1448

10432

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

33.2

919

5958

A10BA02

ATC

metformin; oral

1.5

33.1

1435

10325

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

33.1

1899

14436

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

33.0

1055

7090

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

33.0

1883

14299

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

32.9

332

1508

Z00.8

ICD-10 Finland

Other general examinations

1.9

32.9

513

2791

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

32.9

334

1523

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

32.7

704

4254

M54.2

ICD-10 Finland

Cervicalgia

1.9

32.4

497

2686

J01MA06

ATC

norfloxacin; oral

1.6

32.3

886

5728

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

32.3

743

4578

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

32.2

2035

15724

J01DC02

ATC

cefuroxime; systemic

2.0

32.2

441

2284

A04

ICPC

Weakness/tiredness general

1.6

32.2

910

5929

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

32.0

598

3459

E000006

ATC

1.9

31.9

501

2732

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

31.6

3763

32136

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

31.6

376

1838

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

31.5

2300

18204

R03DA04

ATC

theophylline; systemic, rectal

2.4

31.5

290

1260

ZXA10

NOMESCO Finland

Bilateral

1.5

31.4

1148

7954

XF404

NOMESCO Finland

Ambulatory ECG

1.8

31.4

566

3237

L50

ICD-10 Finland

Urticaria

3.3

31.3

165

512

A01AB09

ATC

miconazole; local oral

1.8

31.3

578

3331

K08.80

ICD-10 Finland

Toothache NOS

1.8

31.3

614

3605

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

31.1

1050

7142

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

31.1

586

3396

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

31.1

2348

18681

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

30.9

468

2518

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

30.8

974

6522

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

30.8

496

2731

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.1

30.7

365

1784

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.0

30.3

419

2180

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.2

29.8

301

1370

W19

ICD-10 Finland

Unspecified fall

1.7

29.8

597

3527

S01GX02

ATC

levocabastine; ophthalmic

1.9

29.7

483

2668

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

29.7

488

2702

ZY010

NOMESCO Finland

Hospital outpatient

1.9

29.6

431

2286

R01AD11

ATC

triamcinolone; nasal

1.7

29.5

632

3808

T90

ICPC

Diabetes non-insulin dependent

1.5

29.3

1160

8166

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

8.6

29.3

L16

ICPC

Ankle symptom/complaint

1.7

29.1

705

4405

M02AA07

ATC

piroxicam; topical

1.4

29.1

2166

17152

D11AH01

ATC

tacrolimus; topical

4.1

28.9

116

288

N06AB06

ATC

sertraline; oral

1.6

28.9

809

5248

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

28.9

264

1145

ZX120

NOMESCO Finland

Intravenous

1.7

28.9

592

3522

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

28.8

280

1250

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

4.0

28.8

118

299

R13

ICD-10 Finland

Dysphagia

2.0

28.8

394

2041

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

28.7

434

2331

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

28.7

486

2721

D02

ICPC

Abdominal pain epigastric

1.9

28.6

416

2206

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

28.6

2491

20212

SPAT1263

SPAT

Sampling

1.3

28.4

2989

24930

D02AX

ATC

Other emollients and protectives

2.3

28.4

269

1186

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

28.3

619

3751

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

28.0

1059

7377

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

27.8

518

2988

J01DA06

ATC

[U] cefuroxime; systemic

1.5

27.8

979

6711

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

27.7

464

2584

A12

ICPC

ALLERGY/ALLERGIC REACTION

7.4

27.5

N17

ICPC

Vertigo/dizziness

1.6

27.5

687

4327

TQW80

NOMESCO Finland

Local dermatologic skincare

2.7

27.4

188

695

P01

ICPC

Feeling anxious/nervous/tense

1.5

27.4

904

6104

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

27.4

568

3388

S21

ICPC

Skin texture symptom/complaint

1.6

27.4

770

5002

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

27.3

1369

10094

N03AE01

ATC

clonazepam; systemic

2.0

27.3

377

1960

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

27.3

557

3307

J04.0

ICD-10 Finland

Acute laryngitis

2.2

27.3

293

1372

R10.0

ICD-10 Finland

Acute abdomen

2.4

27.2

233

978

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

27.2

1100

7770

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

27.1

1728

13301

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

27.1

715

4564

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

27.0

445

2464

R05FB02

ATC

cough suppressants and expectorants

1.3

27.0

2294

18504

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

26.8

329

1632

N06AA09

ATC

amitriptyline; systemic

1.7

26.8

588

3571

E66.8

ICD-10 Finland

Other obesity

1.9

26.7

394

2097

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

26.7

460

2589

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

26.6

473

2689

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.7

26.5

183

680

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

26.5

2152

17222

R12

ICD-10 Finland

Heartburn

1.8

26.4

474

2704

L08

ICPC

Shoulder symptom/complaint

1.5

26.4

1135

8116

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

26.4

1403

10453

SPAT1283

SPAT

Restricted health certificate

1.4

26.4

1536

11633

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

26.3

1058

7462

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

26.2

249

1102

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

26.2

629

3916

UKC02

NOMESCO Finland

Cystoscopy

1.6

26.1

782

5158

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

26.1

348

1786

R4120

NOMESCO Finland

Occupational therapy

1.9

26.0

418

2297

B01AB05

ATC

enoxaparin; parenteral

1.4

25.9

1755

13634

J05AB11

ATC

valaciclovir; oral

1.5

25.9

852

5742

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.5

25.9

212

871

XF402

NOMESCO Finland

ECG with work load test

1.7

25.8

582

3559

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

25.8

4149

36492

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

25.8

979

6818

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

25.8

2642

21866

M04AA01

ATC

allopurinol; systemic

1.7

25.7

564

3419

A29

ICPC

General symptom/complaint other

1.6

25.5

675

4313

Z2446

NOMESCO Finland

Social worker

1.8

25.4

481

2790

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

25.3

1514

11512

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

25.3

354

1850

R52.2

ICD-10 Finland

Other chronic pain

2.3

25.3

240

1062

Y94.0

ICD-10 Finland

Accident at home

3.3

25.3

131

404

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

25.3

700

4526

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

25.2

692

4465

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

25.2

253

1150

SPAT1310

SPAT

Counselling related to known health issue

1.3

25.2

2189

17674

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

25.1

429

2407

C03DA01

ATC

spironolactone; oral

1.7

25.0

527

3158

N89

ICPC

Migraine

2.1

24.9

300

1477

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

24.9

455

2611

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

24.8

763

5060

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

24.8

1264

9334

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

24.6

3873

33878

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

24.6

620

3909

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

24.6

770

5130

F29

ICPC

Eye symptom/complaint other

1.7

24.6

550

3358

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

24.5

427

2411

SPAT1211

SPAT

Application of soft bandage

1.7

24.5

580

3597

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.7

24.3

580

3600

ZXA05

NOMESCO Finland

Left side

1.4

24.3

1436

10887

K02.1

ICD-10 Finland

Caries of dentine

1.3

24.0

4211

37293

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

23.9

1326

9937

C08CA13

ATC

lercanidipine; oral

1.6

23.9

640

4100

A07AA02

ATC

nystatin; oral

1.9

23.9

371

2011

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

23.9

435

2491

Y96.8

ICD-10 Finland

Other type of accident

4.6

23.9

185

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

23.9

874

6033

C09AA05

ATC

ramipril; oral

1.4

23.8

1132

8244

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

23.8

2869

24202

SPAT1260

SPAT

Consultation of another employee

1.4

23.8

1137

8287

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

23.7

263

1251

WX290

NOMESCO Finland

Other blockade of nerve

1.3

23.7

3334

28696

U02

ICPC

Urinary frequency/urgency

1.5

23.7

859

5914

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

23.6

413

2336

C07AB02

ATC

metoprolol; systemic

1.5

23.4

1002

7144

Z50.1

ICD-10 Finland

Other physical therapy

1.9

23.4

337

1778

L02

ICPC

Back symptom/complaint

1.6

23.3

638

4111

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

23.2

442

2569

R51

ICD-10 Finland

Headache

1.8

23.2

396

2219

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

23.2

556

3454

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.2

23.2

209

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

23.2

727

4840

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

23.2

439

2545

X12

ICD-10 Finland

Contact with other hot fluids

4.8

23.2

160

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

23.2

335

1771

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

23.1

1709

13431

R51.81

ICD-10 Finland

Facial pain NOS

2.6

23.1

170

659

J01CA04

ATC

amoxicillin; systemic

1.3

23.0

6190

57769

L29

ICPC

Musculoskeletal sympt/complt other

1.7

23.0

476

2839

H92.0

ICD-10 Finland

Otalgia

1.8

22.9

380

2110

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

22.9

367

2017

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

22.9

306

1572

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

22.8

268

1305

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

22.8

560

3506

A06AD11

ATC

lactulose; oral

1.5

22.6

713

4754

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

22.6

425

2461

338

Kela drug reimbursment

C1-esterase inhibitor, icatibant and conestat alfa

120.4

22.6

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

22.5

1389

10590

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

22.5

663

4347

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

22.4

389

2194

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

22.4

251

1199

N05BA12

ATC

alprazolam; oral

1.6

22.4

633

4111

Z2445

NOMESCO Finland

Psychologist

1.9

22.4

343

1854

WZA90

NOMESCO Finland

Other doctors statement

1.4

22.4

1583

12344

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

22.3

790

5409

A11

ICPC

Chest pain NOS

1.8

22.2

425

2471

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

22.2

661

4347

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

22.2

544

3401

N05CF02

ATC

zolpidem; oral

1.4

22.2

1133

8352

SPAT1058

SPAT

PEF monitoring instruction

1.7

22.2

503

3079

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

22.1

267

1315

W64

ICD-10 Finland

Exposure to other and unspecified animate mechanical forces

4.7

22.0

160

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

22.0

748

5074

R29

ICPC

Respiratory symptom/complaint other

1.8

21.9

421

2455

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

21.9

325

1737

C09CA06

ATC

candesartan; oral

1.4

21.9

1246

9367

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

21.8

389

2213

J01FA15

ATC

telithromycin; oral

1.6

21.7

651

4287

D02AE01

ATC

carbamide; topical

1.7

21.7

443

2632

U01

ICPC

Dysuria/painful urination

1.6

21.7

521

3241

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

21.6

859

6025

M35.7

ICD-10 Finland

Hypermobility syndrome

2.8

21.5

138

494

M54.1

ICD-10 Finland

Radiculopathy

2.1

21.5

244

1172

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

21.5

1102

8130

A08

ICPC

Swelling

2.2

21.4

229

1070

H02AB09

ATC

hydrocortisone; systemic

2.4

21.4

178

739

M54.3

ICD-10 Finland

Sciatica

1.8

21.4

354

1963

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

21.3

2579

21683

R01AC01

ATC

cromoglicic acid; nasal

1.9

21.3

312

1659

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

21.3

2752

23333

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

21.1

401

2328

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

21.1

313

1674

W49

ICD-10 Finland

Exposure to other and unspecified inanimate mechanical forces

3.1

21.1

116

375

L11

ICPC

Wrist symptom/complaint

1.6

21.0

545

3462

T75.4

ICD-10 Finland

Effects of electric current

9.0

21.0

SPAT1252

SPAT

Overall medication plan or its review

1.8

21.0

352

1962

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

20.9

333

1824

H03AA01

ATC

levothyroxine sodium; systemic

1.3

20.9

1509

11793

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

20.8

275

1404

D11AX14

ATC

[U] tacrolimus; topical

4.6

20.8

157

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

20.7

461

2805

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.6

20.7

263

M54

ICD-10 Finland

Dorsalgia

1.5

20.7

730

4990

D84.11

ICD-10 Finland

Hereditary angioedema type I

77.0

20.7

S12

ICPC

Insect bite/sting

1.7

20.7

432

2585

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

20.6

426

2537

A28

ICPC

Limited function/disability NOS

1.5

20.5

660

4416

Z01.2

ICD-10 Finland

Dental examination

1.3

20.5

2986

25654

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

20.5

352

1979

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

20.5

572

3698

SPAT1312

SPAT

General health counselling

1.3

20.3

2288

19028

S01

ICPC

Pain/tenderness of skin

2.0

20.3

273

1408

EBA00

NOMESCO Finland

Extraction of tooth

1.3

20.2

2223

18426

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

4.3

20.2

180

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

20.2

338

1885

H57.1

ICD-10 Finland

Ocular pain

2.1

20.1

230

1111

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

20.1

551

3547

SPAT1255

SPAT

Intravenous administration of medicine

1.8

20.1

368

2112

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

20.1

592

3883

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

20.1

637

4253

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

20.0

263

1343

B01AC04

ATC

clopidogrel; oral

1.5

20.0

650

4359

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

20.0

632

4211

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

20.0

277

1445

K04.0

ICD-10 Finland

Pulpitis

1.5

19.9

677

4590

S04

ICPC

Lump/swelling localized

1.6

19.8

592

3894

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

19.8

638

4276

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

19.8

404

2399

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

19.7

249

1250

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

19.6

333

1867

Z01.7

ICD-10 Finland

Laboratory examination

1.5

19.6

694

4748

D84.13

ICD-10 Finland

Hereditary angioedema type III

105.3

19.6

B06AC02

ATC

icatibant; parenteral

105.3

19.6

M01AX17

ATC

nimesulide; oral

1.4

19.5

1343

10395

S02

ICPC

Pruritus

2.0

19.5

248

1250

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.6

19.4

246

L20

ICPC

Joint symptom/complaint NOS

2.0

19.4

238

1184

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.0

19.4

245

1235

P76

ICPC

Depressive disorder

1.6

19.4

464

2886

C09AA02

ATC

enalapril; systemic

1.4

19.3

919

6677

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

19.3

2791

23911

N03AG01

ATC

valproic acid; systemic, rectal

1.7

19.3

389

2302

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

19.2

350

2009

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

19.2

367

2135

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

19.1

4873

44500

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

19.0

192

877

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

18.9

325

1827

UDC00

NOMESCO Finland

Ear microscopy

1.7

18.9

448

2775

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

18.9

314

1747

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

18.9

505

3229

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

12.7

18.8

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

18.8

757

5319

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

18.8

309

1715

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.9

18.7

114

395

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

18.7

1176

8972

C10AA05

ATC

atorvastatin; oral

1.3

18.6

1791

14554

SPAT1104

SPAT

Monitoring of emergency patient

1.7

18.5

389

2328

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

18.4

371

2192

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

18.4

606

4079

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

15.0

18.4

A99

ICPC

Disease/condition unspecnature/site

1.6

18.4

462

2911

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.1

18.4

317

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

18.3

218

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

18.3

373

2216

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

18.2

209

1012

N76.0

ICD-10 Finland

Acute vaginitis

1.6

18.2

471

2991

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

18.1

322

1832

E000007

ATC

1.7

18.1

395

2391

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

18.1

359

2114

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

18.1

739

5209

F41.00

ICD-10 Finland

Moderate panic disorder

2.5

18.0

137

544

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.2

18.0

178

807

WX320

NOMESCO Finland

Spinalanesthesy

1.3

18.0

1318

10293

JAH01

NOMESCO Finland

Laparoscopy

1.8

18.0

313

1769

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

17.9

169

749

KMAK

NOMESCO Finland

1.2

17.9

3728

33180

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.2

17.9

159

N06AB03

ATC

fluoxetine; oral

1.4

17.9

805

5783

205

Kela drug reimbursment

Chronic hypertension

1.3

17.8

1202

9269

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

17.8

176

799

P03

ICPC

Feeling depressed

1.5

17.7

707

4956

TAB00

NOMESCO Finland

Lumbar puncture

1.8

17.7

294

1635

WVA20

NOMESCO Finland

Medicine administration

2.4

17.6

146

605

A04AA01

ATC

ondansetron; systemic, rectal

1.7

17.6

377

2270

A03FA02

ATC

cisapride; oral, rectal

1.6

17.6

425

2648

D10

ICPC

Vomiting

1.6

17.5

469

3000

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

17.5

1837

15080

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

17.5

338

1975

A10BH01

ATC

sitagliptin; oral

1.6

17.4

433

2719

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

17.4

253

1345

R09

ICPC

Sinus symptom/complaint

1.5

17.4

553

3690

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

17.4

1061

8047

G43.8

ICD-10 Finland

Other migraine

2.6

17.4

125

482

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

17.4

254

1353

WX722

NOMESCO Finland

PEEP

1.9

17.3

244

1282

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

17.3

183

857

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

17.3

231

1191

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.0

17.3

222

1127

G43.3

ICD-10 Finland

Complicated migraine

2.4

17.2

144

603

JN4BD

NOMESCO Finland

Extensive body CT

1.5

17.2

531

3522

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

17.1

483

3134

-1

NOMESCO Finland

1.2

17.1

2437

20764

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

17.0

229

1183

M48.0

ICD-10 Finland

Spinal stenosis

1.5

17.0

536

3570

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

17.0

407

2531

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

17.0

157

691

G43

ICD-10 Finland

Migraine

1.7

16.9

362

2181

WX402

NOMESCO Finland

General anaesthesia

1.4

16.9

1055

8026

R33

ICD-10 Finland

Retention of urine

1.8

16.9

315

1822

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

16.9

325

1894

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

16.9

230

1194

R06.5

ICD-10 Finland

Mouth breathing

1.6

16.9

485

3159

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.0

16.9

324

A02BC04

ATC

rabeprazole; oral

1.5

16.8

519

3439

B02.9

ICD-10 Finland

Zoster without complication

1.8

16.8

295

1672

L86

ICPC

Back syndrome with radiating pain

1.7

16.7

329

1933

H53.2

ICD-10 Finland

Diplopia

2.2

16.7

171

788

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.0

16.7

321

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.7

903

6705

D09

ICPC

Nausea

1.7

16.6

328

1928

J32.4

ICD-10 Finland

Chronic pansinusitis

2.9

16.6

103

363

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

16.5

145

620

SPAT1262

SPAT

Handing over of treatment supplies

1.4

16.5

953

7154

R06AX12

ATC

terfenadine; oral

1.8

16.5

306

1766

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

16.5

765

5520

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

16.5

162

733

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

16.5

402

2510

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

16.5

542

3644

R83

ICPC

Respiratory infection other

1.3

16.5

1829

15107

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

16.4

675

4759

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

16.4

2561

22014

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.8

16.4

305

1761

R25.2

ICD-10 Finland

Cramp and spasm

2.4

16.3

142

607

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

16.3

518

3453

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

16.3

295

1690

I20.09

ICD-10 Finland

Unstable angina

1.9

16.3

225

1173

344

Kela drug reimbursment

Omalizumab

12.1

16.3

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

16.3

233

1232

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

16.3

309

1798

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

16.3

770

5583

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

16.2

659

4637

A02BA04

ATC

nizatidine; systemic

1.6

16.2

386

2396

R03BC03

ATC

nedocromil; inhalant

1.6

16.2

420

2670

C10AA01

ATC

simvastatin; oral

1.3

16.1

1945

16229

M10.9

ICD-10 Finland

Gout, unspecified

1.8

16.1

263

1459

UJD02

NOMESCO Finland

Gastroscopy

1.8

16.0

261

1445

P74

ICPC

Anxiety disorder/anxiety state

1.8

16.0

289

1655

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.6

16.0

202

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

16.0

673

4769

R03BC01

ATC

cromoglicic acid; inhalant

2.5

15.9

127

519

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

15.9

764

5553

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

15.9

363

2229

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

15.8

341

2058

S88

ICPC

Dermatitis contact/allergic

2.4

15.8

140

601

ZXD35

NOMESCO Finland

Usual procedure

2.0

15.8

195

972

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

15.8

135

572

C03AA03

ATC

hydrochlorothiazide; oral

1.6

15.7

434

2797

XA402

NOMESCO Finland

ENMG

2.2

15.7

165

771

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

15.7

640

4504

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

15.6

456

2980

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

15.6

876

6542

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

15.6

209

1080

L13

ICPC

Hip symptom/complaint

1.4

15.6

821

6065

L14

ICPC

Leg/thigh symptom/complaint

1.6

15.5

407

2593

L30.3

ICD-10 Finland

Infective dermatitis

2.0

15.5

202

1031

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.3

15.4

136

586

S22.3

ICD-10 Finland

Fracture of rib

1.7

15.4

318

1895

UJH02

NOMESCO Finland

Anoscopy

1.8

15.4

244

1340

N30

ICD-10 Finland

Cystitis

1.5

15.4

494

3306

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

15.4

316

1882

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

15.3

468

3093

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

15.3

180

881

J33.8

ICD-10 Finland

Other polyp of sinus

2.4

15.3

128

536

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

15.3

168

800

P01BA02

ATC

hydroxychloroquine; oral

1.5

15.2

482

3214

SPAT1153

SPAT

Removal of sutures

1.3

15.2

1791

14876

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.8

15.2

361

K07

ICPC

Swollen ankles/oedema

2.0

15.1

203

1047

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.9

15.1

220

1172

D11AH02

ATC

pimecrolimus; topical

4.7

15.1

110

SPAT1240

SPAT

Therapeutic discussion

1.4

15.1

788

5810

D07AC14

ATC

methylprednisolone aceponate; topical

1.7

15.0

287

1675

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

15.0

482

3225

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

15.0

504

3406

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

15.0

736

5371

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

15.0

421

2728

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.4

15.0

643

4572

T82

ICPC

Obesity

1.8

14.9

243

1344

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

14.9

251

1407

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

14.9

237

1301

S01GX08

ATC

ketotifen; ophthalmic

1.8

14.8

252

1414

C08CA05

ATC

nifedipine; systemic

1.7

14.8

312

1873

K04

ICPC

Palpitations/awareness of heart

1.7

14.8

305

1818

J01

ICD-10 Finland

Acute sinusitis

1.7

14.8

329

2007

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

14.7

877

6614

R03BB01

ATC

ipratropium bromide; inhalant

2.1

14.7

169

822

C02AC05

ATC

moxonidine; oral

1.9

14.7

204

1069

U71

ICPC

Cystitis/urinary infection other

1.6

14.6

376

2383

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

14.6

376

2385

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.9

14.6

152

Y97

ICD-10 Finland

Environmental-pollution-related condition

80.2

14.6

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

2.9

14.5

296

SPAT1281

SPAT

Other administrative function

1.5

14.5

491

3323

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

14.5

351

2189

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

14.5

255

1451

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

14.4

316

1919

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

14.4

189

967

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

14.4

387

2479

R2110

NOMESCO Finland

Giving the first information

1.5

14.4

462

3089

P06

ICPC

Sleep disturbance

1.4

14.4

608

4308

XQ848

NOMESCO Finland

Dermatological photography

2.2

14.4

142

647

R75

ICPC

Sinusitis acute/chronic

1.7

14.4

308

1858

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

14.3

720

5271

C08DA01

ATC

verapamil; systemic

1.9

14.3

207

1100

S98

ICPC

Urticaria

3.5

14.3

195

J30.19

ICD-10 Finland

Pollen allergy UNS

1.9

14.3

213

1146

ZX112

NOMESCO Finland

Subcutaneous

2.4

14.3

124

529

R07

ICPC

Sneezing/nasal congestion

1.5

14.3

469

3156

ZXD20

NOMESCO Finland

Day surgery

1.4

14.2

778

5782

SPAT1216

SPAT

Assessment of functional ability

1.4

14.2

741

5463

R52.0

ICD-10 Finland

Acute pain

1.9

14.2

196

1025

SPAT1301

SPAT

No procedures

1.2

14.2

1944

16419

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

14.1

520

3583

N06AX26

ATC

vortioxetine; oral

1.6

14.1

371

2363

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.5

14.1

473

3193

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.5

14.1

111

451

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

14.1

201

1062

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

14.1

227

1255

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

14.0

241

1358

M01AC06

ATC

meloxicam; systemic, rectal

1.2

14.0

2152

18397

S01GX09

ATC

olopatadine; ophthalmic

2.0

13.9

172

861

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.1

13.9

163

800

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

13.9

332

2067

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

13.9

502

3447

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

13.9

227

1262

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

13.8

298

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

13.8

575

4062

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

13.8

284

1694

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.5

13.8

107

433

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

13.7

463

3133

L20

ICD-10 Finland

Atopic dermatitis

1.9

13.7

198

1052

SPAT1097

SPAT

Recording of ECG

1.4

13.7

732

5416

R60.1

ICD-10 Finland

Generalized oedema

3.9

13.7

141

R97

ICPC

Allergic rhinitis

2.1

13.7

150

716

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.8

13.7

242

1378

H10

ICD-10 Finland

Conjunctivitis

1.6

13.7

402

2636

XQ830

NOMESCO Finland

Exposure to foodstuff

9.7

13.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

13.7

730

5403

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

13.6

185

961

F61.0

ICD-10 Finland

Mixed personality disorders

2.2

13.6

131

588

K80

ICPC

Cardiac arrhythmia NOS

1.6

13.6

380

2461

L09

ICPC

Arm symptom/complaint

1.8

13.6

252

1456

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

13.6

484

3314

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.1

13.6

128

L20.8

ICD-10 Finland

Other atopic dermatitis

3.0

13.5

263

R03DC01

ATC

zafirlukast; oral

2.6

13.5

358

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

13.5

114

482

J01AA04

ATC

lymecycline; systemic

1.3

13.5

889

6808

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

13.5

238

1354

A97

ICPC

No disease

1.3

13.4

925

7134

S20.2

ICD-10 Finland

Contusion of thorax

1.7

13.4

249

1442

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

13.4

393

2575

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

13.4

420

2793

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.7

13.4

159

R4190

NOMESCO Finland

Nutritional therapy

1.8

13.4

239

1366

N02AJ13

ATC

tramadol and paracetamol; systemic

2.3

13.4

122

537

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.4

13.3

596

4272

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

13.3

742

5533

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

13.3

447

3023

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

13.3

365

2352

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

2.6

13.3

374

K07.60

ICD-10 Finland

Snapping jaw

1.6

13.3

340

2156

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

13.3

647

4713

J01MA01

ATC

ofloxacin; systemic

1.5

13.2

408

2706

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

13.2

221

1236

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.2

13.2

219

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

13.2

213

1177

L84

ICPC

Back syndrome without radiat pain

1.7

13.2

255

1493

N06AX12

ATC

bupropion; oral

1.5

13.1

426

2854

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

13.1

348

2224

N04BC05

ATC

pramipexole; oral

1.6

13.1

356

2290

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

13.1

195

1047

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.9

13.1

193

1033

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

13.1

419

2801

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.1

13.0

119

N03AF01

ATC

carbamazepine; oral, rectal

1.7

13.0

257

1515

M89.0

ICD-10 Finland

Algoneurodystrophy

3.0

13.0

254

S10

ICPC

Boil/carbuncle

1.6

13.0

311

1937

S76

ICPC

Skin infection other

1.7

13.0

264

1571

S06

ICPC

Rash localized

1.6

13.0

314

1959

Y94.8

ICD-10 Finland

Other leisure activity accident

2.0

12.9

163

826

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

12.9

256

1510

J01CA08

ATC

pivmecillinam; oral

1.2

12.9

2808

24825

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

12.8

155

771

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

12.8

181

957

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.7

12.8

145

G50.1

ICD-10 Finland

Atypical facial pain

2.3

12.8

112

482

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

12.8

416

2790

D06BB03

ATC

aciclovir; topical

1.7

12.8

291

1787

D09AB01

ATC

zinc bandage without supplements; topical

2.4

12.8

110

471

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

12.8

182

962

J01DA08

ATC

[U] cefaclor; oral

1.3

12.8

853

6545

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

12.7

253

1493

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

12.7

117

515

ZX114

NOMESCO Finland

Intramuscular

2.4

12.7

103

427

R04

ICPC

Breathing problem other

1.9

12.7

186

995

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

12.7

165

845

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

12.7

194

1055

C09AA04

ATC

perindopril; oral

1.8

12.7

220

1245

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

12.7

404

2698

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

12.7

151

745

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

12.6

416

2801

M01AB55

ATC

diclofenac, combinations; oral

1.6

12.6

316

1992

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

12.6

181

960

M54.8

ICD-10 Finland

Other dorsalgia

1.7

12.6

243

1421

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.9

12.6

191

1035

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

12.6

236

1373

G04CA02

ATC

tamsulosin; oral

1.4

12.5

746

5621

R31

ICD-10 Finland

Unspecified haematuria

1.5

12.5

404

2706

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

12.5

852

6558

H01.0

ICD-10 Finland

Blepharitis

1.6

12.5

340

2189

C09CA01

ATC

losartan; oral

1.3

12.5

1117

8937

R03AA01

ATC

epinephrine; inhalant

17.3

12.5

R4140

NOMESCO Finland

Psychotherapy

3.1

12.4

218

J02AC02

ATC

itraconazole; systemic

1.3

12.4

1055

8382

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

12.4

156

788

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

12.4

383

2543

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

12.4

503

3541

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.1

12.4

208

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

12.3

490

3432

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

12.3

246

1457

C07AB12

ATC

nebivolol; oral

2.0

12.3

160

820

-50

ICPC

Medication/prescr/renewal

1.8

12.3

224

1288

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

12.3

872

6752

K59.0

ICD-10 Finland

Constipation

1.6

12.3

286

1768

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

12.3

259

1557

L04

ICPC

Chest symptom/complaint

1.6

12.3

326

2084

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

12.2

672

4997

N03AX11

ATC

topiramate; oral

1.9

12.2

182

981

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

12.2

672

4998

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

12.2

132

628

N05AX12

ATC

aripiprazole; systemic

1.7

12.2

265

1605

D07XC01

ATC

betamethasone, combinations; topical

1.4

12.2

616

4513

K08.3

ICD-10 Finland

Retained dental root

1.6

12.2

335

2162

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.1

12.2

205

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

12.1

427

2917

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

12.1

156

797

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.0

12.1

147

733

S87

ICPC

Dermatitis/atopic eczema

1.9

12.1

166

868

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

12.0

413

2807

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.2

12.0

116

526

K85

ICPC

Elevated blood pressure

1.4

12.0

687

5143

9950A

ICD-9 Finland

Certain adverse effects not elsewhere classified, Other anaphylactic shock

21.3

12.0

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

12.0

184

1003

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

12.0

286

1783

S97

ICPC

Chronic ulcer skin

1.7

11.9

237

1402

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

11.9

142

705

D07AB01

ATC

clobetasone; topical

1.8

11.9

189

1042

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

11.9

733

5556

T68

ICD-10 Finland

Hypothermia

46.7

11.9

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

11.9

396

2673

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

11.8

218

1258

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.3

11.8

109

483

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

11.8

127

603

1220

FHL

Arthroscopy

1.8

11.8

202

1141

C01DA14

ATC

isosorbide mononitrate; oral

1.4

11.8

518

3696

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

11.8

496

3514

R49.08

ICD-10 Finland

Other specified dysphonia

2.1

11.8

129

617

L60.0

ICD-10 Finland

Ingrowing nail

1.7

11.8

247

1483

K04.08

ICD-10 Finland

Other specified pulpit

1.5

11.8

421

2885

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

11.7

174

937

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.2

11.7

116

531

R03DX05

ATC

omalizumab; parenteral

10.5

11.7

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.0

11.7

144

721

SPAT1324

SPAT

Screening procedure

0.8

11.7

837

10530

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

11.7

234

1386

-60

ICPC

Result test/procedure

1.6

11.7

329

2139

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.7

11.7

218

1265

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

11.6

268

1653

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

11.6

183

1006

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.8

11.6

213

1231

SPAT1307

SPAT

Psychosocial counselling and guidance

1.4

11.6

482

3408

D03

ICPC

Heartburn

1.8

11.6

190

1057

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.0

11.6

150

768

X28

ICD-10 Finland

Contact with other specified venomous plants

65.0

11.6

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.2

11.6

115

528

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

11.5

235

1403

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.8

11.5

197

1113

E000004

ATC

2.0

11.5

136

672

L04AD01

ATC

ciclosporin; systemic

2.2

11.5

112

510

I50.0

ICD-10 Finland

Congestive heart failure

1.7

11.5

231

1373

P29

ICPC

Psychological sympt/compl other

1.5

11.5

396

2695

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

11.5

149

765

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

11.5

166

888

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

11.5

630

4684

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.9

11.4

237

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

11.4

167

894

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.9

11.4

155

809

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

11.4

402

A01AB04

ATC

amphotericin B; local oral

1.7

11.4

228

1350

A13

ICPC

Concern/fear medical treatment

2.4

11.4

376

RD210

NOMESCO Finland

2.0

11.3

133

657

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.3

11.3

103

455

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

7.8

11.3

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

6.0

11.3

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

4.7

11.3

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

11.3

370

2492

S92.5

ICD-10 Finland

Fracture of other toe

1.9

11.3

160

849

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

11.2

216

1264

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.3

11.2

105

470

W80

ICD-10 Finland

Inhalation and ingestion of other objects causing obstruction of respiratory tract

8.9

11.2

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

11.2

552

4029

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

7.2

11.2

K03.80

ICD-10 Finland

Irradiated enamel

1.6

11.2

291

1856

R25.1

ICD-10 Finland

Tremor, unspecified

2.0

11.2

147

759

C05AA08

ATC

fluocortolone; rectal, topical

1.3

11.2

760

5848

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

11.2

173

947

N06AX05

ATC

trazodone; oral

1.9

11.2

159

845

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

11.1

332

2184

EMB10

NOMESCO Finland

Tonsillectomy

1.5

11.1

429

2987

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

11.1

219

1295

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

11.1

133

661

3DX05

NOMESCO Finland

20.0

11.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.3

11.1

K04.09

ICD-10 Finland

Pulpit UNS

1.7

11.1

249

1526

N03AF02

ATC

oxcarbazepine; oral

1.8

11.1

182

1018

N05CD07

ATC

temazepam; oral

1.4

11.0

540

3933

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

11.0

144

742

R49.01

ICD-10 Finland

Functional dysphonia

1.8

11.0

170

929

U07

ICPC

Urine symptom/complaint other

1.6

11.0

300

1932

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.9

11.0

154

813

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

11.0

281

1781

P25

ICPC

Phase of life problem adult

1.6

11.0

273

1718

49300

ICD-8 Finland

Asthma, bronchiale

2.1

11.0

125

608

N64.4

ICD-10 Finland

Mastodynia

1.8

11.0

177

980

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.7

11.0

207

1208

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

5.3

11.0

F32

ICD-10 Finland

Depressive episode

1.5

11.0

347

2317

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

11.0

287

1834

R35

ICD-10 Finland

Polyuria

1.6

10.9

285

1817

L50.2

ICD-10 Finland

Urticaria due to cold and heat

4.8

10.9

J01CF05

ATC

flucloxacillin; systemic

1.7

10.9

203

1180

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

10.9

383

2614

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

10.9

343

2286

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

10.9

178

991

R30.0

ICD-10 Finland

Dysuria

1.7

10.9

204

1188

K29.1

ICD-10 Finland

Other acute gastritis

2.6

10.9

315

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.9

10.9

155

826

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

10.9

112

523

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.4

10.8

369

XG460

NOMESCO Finland

Short time oxymetry

2.6

10.8

300

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

10.8

114

539

WX882

NOMESCO Finland

High dependency care

1.9

10.8

156

836

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.4

10.7

363

N06AB05

ATC

paroxetine; oral

1.5

10.7

369

2509

S01GX04

ATC

nedocromil; ophthalmic

2.1

10.7

112

528

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

10.7

271

1717

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

10.7

389

2680

R03CC02

ATC

salbutamol; systemic

1.4

10.7

468

3345

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

10.7

487

3504

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.0

10.7

132

667

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

10.6

458

3261

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

10.6

157

846

R01AC02

ATC

levocabastine; nasal

1.8

10.6

180

1015

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

10.6

187

1065

K11.2

ICD-10 Finland

Sialoadenitis

1.8

10.6

178

1001

XCK00

NOMESCO Finland

Perimetry

1.5

10.6

309

2027

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

10.6

242

1491

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.5

10.6

334

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

3.1

10.5

182

N06AA12

ATC

doxepin; systemic

1.6

10.5

255

1596

S70.0

ICD-10 Finland

Contusion of hip

1.8

10.5

164

901

D19

ICPC

Teeth/gum symptom/complaint

1.2

10.5

1725

14774

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.7

10.5

220

1325

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

3.6

10.5

124

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

10.5

261

1643

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.8

10.5

173

967

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

10.5

204

1201

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

2.9

10.5

222

S90.0

ICD-10 Finland

Contusion of ankle

2.1

10.5

117

567

SPAT1057

SPAT

Peak expiratory flow measurement

2.0

10.5

128

642

DHB50

NOMESCO Finland

Turbinoplasty

1.8

10.5

165

909

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

10.5

748

5796

I20.00

ICD-10 Finland

Unstable angina

2.1

10.5

117

568

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.1

10.4

119

582

D06BX01

ATC

metronidazole; topical

1.4

10.4

617

4644

D84.12

ICD-10 Finland

Hereditary angioedema type II

+∞

10.4

R5599

NOMESCO Finland

Other rehabilitation service

1.8

10.4

165

913

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.5

10.4

346

2338

I49.1

ICD-10 Finland

Atrial premature depolarization

1.8

10.4

164

904

N06AX03

ATC

mianserin; oral

1.6

10.3

243

1508

D84.1

ICD-10 Finland

Defects in the complement system

16.0

10.3

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

10.3

177

1003

R01

ICPC

Pain respiratory system

2.2

10.3

103

475

SPAT1059

SPAT

Spirometry at the office

1.6

10.3

262

1661

XQ810

NOMESCO Finland

Physical test for urticaria

8.2

10.3

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

10.3

207

1231

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.4

10.3

372

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

10.3

771

6014

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

10.2

124

620

H29

ICPC

Ear symptom/complaint other

1.4

10.2

539

3978

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.0

10.2

133

685

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

10.2

126

634

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.5

10.2

328

J03

ICD-10 Finland

Acute tonsillitis

1.8

10.2

180

1030

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

10.2

194

1133

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

10.2

145

770

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

10.2

674

5159

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

10.2

3652

33480

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.2

10.2

102

471

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

10.2

514

3771

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

10.1

139

731

C10AA07

ATC

rosuvastatin; oral

1.3

10.1

1107

9067

-69

ICPC

Other reason for encounter NEC

1.7

10.1

219

1332

R04.2

ICD-10 Finland

Haemoptysis

1.9

10.1

138

724

SPAT1229

SPAT

Assessment of need for aid

1.5

10.1

348

2369

V01AA02

ATC

grass pollen; systemic

4.1

10.1

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

10.1

442

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.0

292

1915

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

1.9

10.0

135

703

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

10.0

113

550

S62.6

ICD-10 Finland

Fracture of other finger

1.6

10.0

244

1531

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

10.0

118

587

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

9.9

145

779

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

9.9

126

642

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

9.9

342

2331

ZX108

NOMESCO Finland

Inhalation

3.3

9.9

141

C08CA02

ATC

felodipine; oral

1.5

9.9

362

2498

UDM02

NOMESCO Finland

Sinoscopy

1.9

9.9

132

686

M77.4

ICD-10 Finland

Metatarsalgia

1.5

9.9

307

2047

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

5.0

9.8

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

9.8

201

1203

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.0

9.8

119

599

M23.8

ICD-10 Finland

Other internal derangements of knee

1.6

9.8

219

1342

V01AA05

ATC

tree pollen; parenteral

2.8

9.8

226

L18

ICPC

Muscle pain

1.7

9.8

209

1267

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

9.7

204

1230

K04.00

ICD-10 Finland

Hyperemia of pulp

1.6

9.7

270

1749

R07.1

ICD-10 Finland

Chest pain on breathing

2.3

9.7

376

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.0

9.7

118

592

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.5

9.7

293

1935

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

9.7

243

1534

D11AX15

ATC

[U] pimecrolimus; topical

4.5

9.7

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

9.7

403

2853

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

9.7

198

1187

K92.0

ICD-10 Finland

Haematemesis

2.0

9.7

111

546

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

9.6

370

U13

ICPC

Bladder symptom/complaint other

1.8

9.6

160

900

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

9.6

244

1549

N02CC04

ATC

rizatriptan; oral

1.4

9.6

387

2723

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.1

9.6

466

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

9.6

432

3102

XKD00

NOMESCO Finland

Uroflowmetry

1.4

9.6

576

4346

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

9.6

192

1145

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

9.6

235

1479

M01AB01

ATC

indometacin; systemic, rectal

1.5

9.5

297

1977

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.5

9.5

279

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.8

9.5

170

976

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

9.5

117

591

C09CA03

ATC

valsartan; oral

1.5

9.5

370

2586

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

3.0

9.5

168

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

9.5

1138

9420

E87.6

ICD-10 Finland

Hypokalaemia

1.9

9.5

139

748

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

9.5

326

2220

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

9.5

794

6289

R04.0

ICD-10 Finland

Epistaxis

1.5

9.5

301

2017

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

9.5

375

2631

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

9.5

577

4364

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

9.5

362

2521

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

3.8

9.5

100

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.2

9.4

454

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

9.4

178

1039

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.0

9.4

118

601

N05AH03

ATC

olanzapine; systemic

1.5

9.4

350

2425

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

9.4

611

4668

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.4

9.4

312

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

9.4

120

615

DPA30

NOMESCO Finland

Sphenotomy

3.4

9.4

126

S14

ICPC

Burn/scald

1.7

9.4

190

1136

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

9.4

115

580

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

9.3

266

1737

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

1.9

9.3

132

702

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

9.3

155

869

L50.5

ICD-10 Finland

Cholinergic urticaria

8.0

9.3

W86

ICD-10 Finland

Exposure to other specified electric current

8.0

9.3

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.3

9.3

650

5021

SPAT1325

SPAT

Vaccination

1.2

9.3

1973

17285

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.4

9.3

446

3243

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

9.3

312

2115

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

3.0

9.3

171

AN1

Coronary angiography

1.4

9.3

428

3088

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.1

9.3

452

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

9.2

292

1950

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

9.2

137

740

R07.2

ICD-10 Finland

Precordial pain

2.1

9.2

101

488

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

9.2

302

2034

F03

ICPC

Eye discharge

1.4

9.2

367

2579

395

Kela drug reimbursment

Dupilumab

13.7

9.2

S50.0

ICD-10 Finland

Contusion of elbow

1.8

9.2

152

855

A27

ICPC

Fear of other disease NOS

1.6

9.2

226

1425

R81

ICPC

Pneumonia

1.8

9.1

159

905

A10AE04

ATC

insulin glargine; parenteral

1.4

9.1

422

3047

L04AB04

ATC

adalimumab; parenteral

2.0

9.1

116

595

N06AX22

ATC

agomelatine; oral

1.8

9.1

142

782

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.8

9.1

196

M03BX01

ATC

baclofen; systemic

2.1

9.1

104

509

N20.1

ICD-10 Finland

Calculus of ureter

1.7

9.1

168

977

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

9.1

283

1887

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.3

9.1

354

H65.0

ICD-10 Finland

Acute serous otitis media

2.1

9.1

102

498

E86

ICD-10 Finland

Volume depletion

2.1

9.1

441

D84.19

ICD-10 Finland

Unspecified defect in the complement system

11.4

9.0

B01AB10

ATC

tinzaparin; parenteral

1.5

9.0

325

2236

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.0

9.0

108

539

L04AA13

ATC

leflunomide; oral

1.9

9.0

133

717

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

9.0

6664

64407

J47

ICD-10 Finland

Bronchiectasis

2.3

9.0

338

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

9.0

158

905

F43.0

ICD-10 Finland

Acute stress reaction

1.5

9.0

295

1990

S43.0

ICD-10 Finland

Dislocation of shoulder joint

1.7

9.0

181

1081

G04BD08

ATC

solifenacin; oral

1.5

9.0

286

1918

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

9.0

318

2180

V01.9

ICD-10 Finland

Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident

4.2

8.9

M01AH02

ATC

rofecoxib; oral

1.3

8.9

616

4750

JEA00

NOMESCO Finland

Appendectomy

1.4

8.9

362

2549

A06AC51

ATC

ispaghula, combinations; systemic

1.5

8.9

258

1691

B01AF02

ATC

apixaban; oral

1.4

8.9

359

2524

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.3

8.9

352

M75.8

ICD-10 Finland

Other shoulder lesions

1.7

8.9

189

1146

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

8.9

155

886

F01

ICPC

Eye pain

1.7

8.9

164

955

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

2.7

8.9

211

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

8.9

111

564

G01AF02

ATC

clotrimazole; vaginal

1.6

8.8

205

1274

N06BA04

ATC

methylphenidate; oral

1.7

8.8

162

942

WW200

NOMESCO Finland

Immunization

1.8

8.8

151

859

T92

ICPC

Gout

2.3

8.8

324

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.3

8.8

324

F44.4

ICD-10 Finland

Dissociative motor disorders

6.8

8.8

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

8.8

145

814

A10BJ06

ATC

semaglutide; parenteral

1.8

8.8

154

879

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

3.5

8.8

112

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

8.8

163

948

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

8.8

329

2284

H53.4

ICD-10 Finland

Visual field defects

2.0

8.8

100

492

ACC51

NOMESCO Finland

Release of median nerve

1.4

8.8

374

2661

R30.9

ICD-10 Finland

Painful micturition, unspecified

3.2

8.8

139

J02.0

ICD-10 Finland

Streptococcal pharyngitis

1.8

8.7

133

727

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

8.7

292

1977

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.0

8.7

156

J38.4

ICD-10 Finland

Oedema of larynx

3.4

8.7

118

L71.9

ICD-10 Finland

Rosacea, unspecified

1.9

8.7

121

643

XQ812

NOMESCO Finland

Contact urticaria assay

14.0

8.7

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

1.8

8.7

144

811

L19

ICPC

Muscle symptom/complaint NOS

1.8

8.7

134

736

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

8.7

758

6039

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.7

8.6

160

931

A10BH05

ATC

linagliptin; oral

1.7

8.6

174

1038

C08DB01

ATC

diltiazem; oral

1.7

8.6

179

1076

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

8.6

122

650

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.0

8.6

105

529

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.8

8.6

134

739

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.2

8.6

130

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

3.0

8.6

152

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.3

8.6

545

4146

F43.00

ICD-10 Finland

Acute stress reaction mild

1.7

8.6

156

904

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

3.6

8.6

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.1

8.6

434

A10BB12

ATC

glimepiride; oral

1.5

8.6

242

1580

N02CC07

ATC

frovatriptan; oral

1.5

8.6

281

1896

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.2

8.5

359

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.9

8.5

117

616

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.9

8.5

119

631

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.9

8.5

127

689

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

8.5

394

2847

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.8

8.5

131

720

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

3.6

8.5

100

H81.3

ICD-10 Finland

Other peripheral vertigo

1.8

8.5

135

752

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

8.5

296

2024

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

8.5

392

2833

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.0

8.5

106

540

N05AE04

ATC

ziprasidone; systemic

2.6

8.5

222

F43.8

ICD-10 Finland

Other reactions to severe stress

1.8

8.5

138

771

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.5

8.5

265

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

8.4

595

4601

G01AF04

ATC

miconazole; vaginal

1.5

8.4

284

1929

C09BA02

ATC

enalapril and diuretics; systemic

1.5

8.4

323

2252

ZX100

NOMESCO Finland

Oral

2.3

8.4

323

K92.1

ICD-10 Finland

Melaena

1.6

8.4

207

1305

M67.4

ICD-10 Finland

Ganglion

1.4

8.4

358

2545

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

8.4

134

744

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

8.4

223

1434

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

8.4

429

3151

J01DB05

ATC

cefadroxil; oral

1.5

8.4

246

1617

L10

ICPC

Elbow symptom/complaint

1.5

8.4

249

1641

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

8.4

202

1268

A10BK03

ATC

empagliflozin; oral

1.5

8.4

298

2045

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

8.4

130

716

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.0

8.4

481

O21.0

ICD-10 Finland

Mild hyperemesis gravidarum

2.4

8.4

275

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.8

8.4

178

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.2

8.3

390

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

2.9

8.3

172

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

8.3

206

1301

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

8.3

327

2290

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

8.3

105

538

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.7

8.3

202

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

8.3

141

802

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.8

8.3

141

802

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.0

8.3

462

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.0

8.3

100

501

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.6

8.3

181

1109

R06AX11

ATC

astemizole; oral

1.6

8.3

189

1170

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

1.9

8.3

117

625

R06AX18

ATC

acrivastine; oral

1.7

8.2

160

947

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

1.9

8.2

113

598

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

8.2

117

627

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

3.1

8.2

135

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.0

8.2

492

F05

ICPC

Visual disturbance other

1.8

8.2

134

750

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

8.2

310

2159

N83.1

ICD-10 Finland

Corpus luteum cyst

2.1

8.2

435

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.5

8.1

240

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.9

8.1

114

606

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

3.4

8.1

109

M76.6

ICD-10 Finland

Achilles tendinitis

1.6

8.1

226

1468

M01AH03

ATC

valdecoxib; oral

1.5

8.1

302

2093

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.5

8.1

240

1584

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

8.1

361

2590

K07.61

ICD-10 Finland

Cracking jaw joint

1.8

8.1

124

681

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

8.1

4942

46755

Z58.8

ICD-10 Finland

Other problems related to physical environment

5.7

8.1

N63

ICD-10 Finland

Unspecified lump in breast

1.4

8.1

362

2599

G83.4

ICD-10 Finland

Cauda equina syndrome

3.8

8.1

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

8.1

179

1098

N06AA10

ATC

nortriptyline; systemic

1.9

8.1

118

638

L04AX01

ATC

azathioprine; systemic

1.5

8.1

241

1594

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.2

8.1

349

S62.0

ICD-10 Finland

Fracture of navicular [scaphoid] bone of hand

2.4

8.1

268

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.2

8.1

372

A77

ICPC

Viral disease other/NOS

1.6

8.0

214

1377

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

8.0

135

766

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.6

8.0

218

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

8.0

406

2983

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.4

8.0

354

2538

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

8.0

240

1589

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

8.0

472

3554

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

8.0

123

677

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

8.0

183

1135

L99

ICPC

Musculoskeletal disease other

2.0

8.0

497

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

8.0

223

1455

Y96

ICD-10 Finland

Work-related condition

4.3

8.0

N02CC06

ATC

eletriptan; oral

1.5

8.0

227

1484

G54.0

ICD-10 Finland

Brachial plexus disorders

1.7

8.0

143

827

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

7.9

205

1309

L01

ICD-10 Finland

Impetigo

2.1

7.9

423

S15

ICPC

Foreign body in skin

1.5

7.9

301

2098

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

7.9

150

882

L90

ICPC

Osteoarthrosis of knee

1.5

7.9

257

1733

S01GX05

ATC

lodoxamide; ophthalmic

2.1

7.9

380

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.5

7.9

231

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.1

7.9

429

G01AF01

ATC

metronidazole; vaginal

1.3

7.9

542

4179

7088X

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA ALIA DEFINITA]

13.0

7.9

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

7.8

156

928

K05.0

ICD-10 Finland

Acute gingivitis

1.7

7.8

142

823

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

7.8

494

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.1

7.8

396

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

7.8

161

967

280

Kela drug reimbursment

Clopidogrel

2.4

7.8

251

B00.11

ICD-10 Finland

Herpes simplex labialis

2.1

7.8

419

RS210

NOMESCO Finland

3.8

7.8

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.4

7.8

260

H60

ICD-10 Finland

Otitis externa

1.5

7.8

251

1688

SPAT1360

SPAT

Extensive global examination

1.4

7.8

374

2721

F02

ICPC

Red eye

1.5

7.8

231

1525

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

285

44.57

307.65

1.1

u/ml

0.4

0.0

1.39

171

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

993

2252

4.84

307.65

1.7

1.8

g/l

0.2

1.27

904

2143

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

311

156

20.62

307.65

1.2

u/ml

11.6

9.9

0.12

232

115

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

593

186

34.08

307.65

1.3

1.2

111.4

111.3

0.02

540

161

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

610

210

31.10

307.65

1.3

1.2

g/l

0.3

1.51

476

170

(3005322) IgE [Units/volume] in Serum or Plasma

1636

5178

3.64

307.65

1.5

1.3

u/ml

407.2

219.3

4.71

1576

4777

(3011897) Casein IgE Ab [Units/volume] in Serum

284

146

20.06

307.65

1.4

1.3

u/ml

15.6

0.5

1.73

(3019420) Tryptase [Mass/volume] in Serum or Plasma

671

346

20.89

307.65

1.5

1.4

ug/l

7.3

7.2

0.02

578

310

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

994

2324

4.69

307.65

1.7

1.8

g/l

1.2

1.67

911

2215

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

199

29.05

298.36

1.0

u/ml

0.3

0.0

1.69

117

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

189

26.43

274.35

1.1

u/ml

5.4

0.2

1.05

111

(3012494) Peanut IgE Ab [Units/volume] in Serum

291

273

10.98

269.80

1.1

u/ml

16.7

15.0

0.05

218

155

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

195

23.16

269.32

1.1

u/ml

4.4

1.9

0.90

149

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

182

26.15

263.21

1.1

u/ml

0.8

0.1

1.20

106

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

174

27.28

255.49

1.1

1.0

u/ml

0.8

0.1

1.61

101

(3011841) English Walnut IgE Ab [Units/volume] in Serum

185

20.74

244.22

1.1

u/ml

7.2

3.0

0.69

142

(3022096) Basophils/100 leukocytes in Blood

4935

33306

2.08

240.73

7.0

6.2

0.6

0.7

3.57

4671

31108

(3006504) Eosinophils/100 leukocytes in Blood

5034

34427

2.06

234.29

6.9

6.2

2.9

2.8

2.63

4755

32137

(3019069) Monocytes/100 leukocytes in Blood

5048

34613

2.05

232.56

7.1

6.4

8.2

8.4

4.69

4803

32519

(3006315) Basophils [#/volume] in Blood

5263

36810

2.05

227.32

6.8

6.0

e9/l

0.0

0.68

4637

31986

(3013115) Eosinophils [#/volume] in Blood

5397

38114

2.05

226.61

7.1

6.2

e9/l

0.2

7.67

4842

33688

(3001604) Monocytes [#/volume] in Blood

5243

36666

2.04

225.95

6.8

6.0

e9/l

0.6

0.69

4624

31896

(3002030) Lymphocytes/100 leukocytes in Blood

5153

35859

2.03

224.60

7.0

6.2

28.6

29.1

2.85

4899

33541

(3018010) Neutrophils/100 leukocytes in Blood

5084

35365

2.02

219.93

6.8

6.0

56.9

56.4

2.37

4832

33201

(42870588) Differential panel, method unspecified - Blood

3862

24421

2.02

218.77

6.5

6.2

—

(3019198) Lymphocytes [#/volume] in Blood

5343

37970

2.01

215.70

6.9

6.0

e9/l

2.0

0.63

4826

33671

(3013650) Neutrophils [#/volume] in Blood by Automated count

5765

42237

2.03

211.52

9.6

9.0

e9/l

4.2

4.0

11.27

5106

36970

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

125

27.55

184.28

1.0

u/ml

1.5

2.7

0.19

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

128

20.93

169.89

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

127

20.12

165.71

1.0

u/ml

1.3

1.9

0.19

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

112

25.77

161.30

1.0

u/ml

17.4

19.4

0.09

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4833

35169

1.82

159.97

6.4

5.9

umol/l

10.5

11.0

1.66

4603

33183

(3016031) Almond IgE Ab [Units/volume] in Serum

119

21.15

158.66

1.1

u/ml

0.8

1.3

0.40

(3002582) Erythrocytes [#/volume] in Urine

3165

20338

1.86

156.76

3.7

3.0

e6/l

57.3

81.2

0.39

2506

15323

(3021589) Normoblasts [#/volume] in Blood

4551

32723

1.80

154.85

10.7

9.0

e9/l

0.0

2.09

3746

26742

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

103

28.93

154.39

1.1

1.0

u/ml

0.9

0.1

1.33

(3013707) Erythrocyte sedimentation rate by Westergren method

6656

53862

1.92

151.98

4.9

3.9

mm/h

11.8

10.9

6.25

6256

50229

(3030467) Casts [#/volume] in Urine by Automated count

2937

18700

1.85

147.88

3.7

3.0

e6/l

0.3

0.4

1.54

2260

13866

(36304419) Bacteria [Presence] in Urine

2902

18455

1.85

146.36

3.6

2.9

—

(3018095) Leukocytes [#/volume] in Urine

3627

24679

1.79

146.14

4.4

3.5

e6/l

89.5

87.2

0.04

2642

16720

(3013826) Glucose [Moles/volume] in Serum or Plasma

5298

40236

1.78

145.71

5.7

4.5

mmol/l

6.5

0.20

5023

36988

(40758558) Short blood count panel - Blood

2872

18266

1.84

144.39

6.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2611

16127

1.87

144.05

2.1

1.8

mg/l

0.9

1.1

3.10

1923

12039

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6600

53718

1.88

141.98

8.7

7.2

u/l

76.5

76.8

0.19

6294

50633

(3023368) Bacteria identified in Blood by Culture

2632

16465

1.85

138.42

4.9

4.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

107

19.68

138.32

1.1

1.0

u/ml

7.6

7.7

0.01

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

109

17.79

134.49

1.4

u/ml

11.0

1.2

1.05

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4436

32792

1.70

127.02

7.6

6.5

mmol/l

1.2

0.05

3824

27717

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2900

19078

1.77

126.63

2.5

2.1

u/l

169.2

207.8

0.89

2750

17947

(3026782) Osmolality of Urine

2160

13014

1.87

126.08

3.1

2.6

mosm/kgh2o

531.9

541.7

1.12

1881

11034

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4091

29660

1.70

125.38

7.0

5.9

mmol/l

1.2

0.54

3750

26960

(3037467) Urinalysis macro (dipstick) panel - Urine

6218

50610

1.75

122.64

5.3

4.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

233

425

5.60

121.34

1.7

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8313

74759

2.61

119.72

19.0

12.2

mg/l

19.6

21.5

7.15

7060

58010

(3033658) Prothrombin time (PT) actual/Normal

2676

17458

1.76

118.69

4.7

3.9

94.1

93.0

1.53

2611

16998

(3003888) Timothy IgE Ab [Units/volume] in Serum

531

1816

3.05

116.81

1.1

u/ml

4.9

5.9

0.86

382

985

(3000850) Epithelial cells [#/volume] in Urine

2250

14023

1.81

116.23

3.0

2.5

e6/l

6.9

6.6

0.39

2002

12194

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3353

23402

1.69

115.73

4.1

3.2

ng/l

24.7

67.7

1.20

1969

13818

(3031040) Bacteria [#/volume] in Urine by Automated count

5969

48383

1.70

115.63

5.5

4.1

e6/l

456.2

1413.6

2.60

573

(3037522) Nuclear Ab [Titer] in Serum

1810

10637

1.88

112.55

1.5

1.4

titre

563.0

561.9

0.01

345

2175

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1965

11859

1.84

112.25

4.2

3.4

ng/l

209.3

514.9

2.45

1300

8173

(3032080) INR in Blood by Coagulation assay

3488

24790

1.67

111.09

8.4

7.5

inr

1.1

1.2

3.03

1158

7544

(3010726) Horse dander IgE Ab [Units/volume] in Serum

503

1725

3.03

110.01

1.1

u/ml

3.9

2.3

1.13

162

455

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3100

21445

1.68

108.98

3.0

2.5

u/l

54.4

57.7

2.82

2869

19820

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

254

549

4.73

108.93

1.2

1.3

u/ml

1.3

1.1

0.09

227

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

553

2031

2.84

106.77

1.2

1.1

u/ml

2.2

1.5

0.86

347

848

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1780

10593

1.85

105.57

3.1

2.8

e6/l

3.9

3.2

1.55

962

5596

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

33.24

103.18

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3848

28555

1.61

99.80

5.3

4.8

g/l

36.1

0.36

3624

26574

(3008401) Mugwort IgE Ab [Units/volume] in Serum

488

1737

2.91

99.72

1.1

u/ml

1.5

1.1

0.52

333

769

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1690

10067

1.84

99.22

2.1

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

14.49

98.86

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

8160

73793

2.22

98.53

19.5

13.3

mmol/l

139.5

139.6

3.76

8035

71839

(3036312) Salmon IgE Ab [Units/volume] in Serum

17.02

97.88

1.2

1.0

u/ml

1.4

1.2

0.12

(3023103) Potassium [Moles/volume] in Serum or Plasma

8170

74022

2.21

96.46

19.7

13.4

mmol/l

3.9

14.49

8029

71880

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7660

67885

1.90

95.69

16.1

11.0

ml/min/173m2

88.1

86.9

5.31

6653

55352

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1204

6510

1.98

94.65

2.6

2.4

u/l

33.2

44.0

0.81

1024

5571

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1822

11343

1.76

91.34

3.0

2.6

e6/l

1.4

1.1

0.33

1011

6309

(3015076) Soybean IgE Ab [Units/volume] in Serum

234

546

4.37

91.17

1.2

1.0

u/ml

0.5

1.6

0.64

(3018418) pH of Serum or Plasma

2763

19326

1.62

88.73

4.5

3.9

7.4

0.15

536

3762

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3569

26522

1.58

88.72

2.1

1.9

pmol/l

95.1

97.3

2.09

1955

13925

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3282

23946

1.59

88.16

3.3

3.2

u/l

30.9

32.8

0.55

3098

22788

(40768797) Stomach Pathology biopsy report

1566

9418

1.80

87.97

1.3

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1595

9765

1.77

83.92

2.3

2.4

29.9

29.6

0.71

1551

9457

(3026008) Bacteria identified in Urine by Culture

2908

20811

1.59

83.79

3.3

2.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6839

59350

1.65

83.41

4.7

4.1

pmol/l

14.5

14.6

0.78

6354

54592

(3020874) Milk IgE Ab [Units/volume] in Serum

241

623

3.95

81.86

1.3

1.1

u/ml

11.3

0.8

2.13

157

196

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2595

18161

1.60

81.74

1.9

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2372

16277

1.62

80.88

1.6

1.4

g/l

2.2

0.06

1409

10100

(3014599) Egg white IgE Ab [Units/volume] in Serum

238

618

3.93

80.33

1.2

1.1

u/ml

10.9

1.9

1.26

148

172

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7685

69047

1.81

79.87

5.7

4.8

mu/l

1.8

2.0

2.88

7232

64256

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1188

6766

1.87

78.89

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1191

6813

1.86

77.94

2.0

1.7

—

(3000492) Spirometry study

1230

7167

1.83

75.71

1.5

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1372

8296

1.77

74.50

1.9

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1635

10480

1.69

71.67

4.0

3.7

mmol/l

0.8

0.59

1534

9814

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1317

7958

1.77

71.43

2.9

umol/l

6.6

7.2

0.66

1117

6822

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1980

13352

1.62

71.00

1.4

1.3

iu/ml

28.5

30.0

0.17

539

4127

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1898

12689

1.63

70.41

1.4

1.3

u/ml

8.8

11.2

0.87

673

5186

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2606

18854

1.54

68.46

1.4

1.3

u/ml

1.5

1.7

0.42

673

5177

(3014111) Lactate [Moles/volume] in Serum or Plasma

953

5334

1.88

66.13

7.8

7.2

mmol/l

1.4

1.3

0.75

928

5132

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5930

50839

1.49

66.09

3.7

2.9

u/l

45.6

41.3

3.16

5603

47945

(3042936) Bacteria identified in Isolate by Culture

1471

9355

1.69

65.84

2.1

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1607

10481

1.65

65.19

2.5

2.4

ug/g

119.2

120.7

0.06

1264

8236

(3015377) Calcium [Moles/volume] in Serum or Plasma

3014

22685

1.50

64.83

3.4

3.3

mmol/l

2.4

0.38

2675

20000

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8356

78031

2.10

64.73

19.8

13.6

umol/l

73.5

72.5

1.99

8356

78002

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2202

15506

1.56

64.69

3.0

2.9

ng/l

1195.0

1170.5

0.09

1839

13026

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3844

30388

1.47

64.36

2.6

2.3

nmol/l

74.2

75.7

2.52

3515

27821

(3012544) pH of Venous blood

1020

5895

1.82

63.77

5.0

4.4

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

996

5716

1.84

63.71

5.1

4.4

kpa

5.8

0.22

968

5552

(3021601) Nitrite [Presence] in Urine by Test strip

4455

36269

1.46

63.69

5.7

4.6

estimate

0.0

0.37

1001

7063

(3002032) Base excess in Venous blood by calculation

992

5688

1.84

63.63

5.1

4.4

mmol/l

1.8

0.05

819

4612

(3000991) Gas panel - Venous blood

939

5299

1.86

63.37

9.8

8.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1595

10472

1.64

62.76

2.7

2.4

umol/l

12.9

13.7

3.83

1462

9758

(3009261) Glucose [Presence] in Urine by Test strip

4479

36582

1.45

62.44

4.2

3.4

estimate

0.0

0.11

970

6884

(3035350) Ketones [Presence] in Urine by Test strip

4429

36137

1.45

61.83

4.1

3.4

estimate

0.0

1.08

972

6856

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4380

35701

1.45

61.25

3.4

2.9

ug/l

101.5

98.3

0.36

4099

33498

(3026493) Urate [Moles/volume] in Serum or Plasma

2366

17112

1.52

60.83

2.7

2.5

umol/l

2701.1

3840.3

0.97

2075

15063

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1477

9591

1.65

60.49

2.7

2.4

g/l

2.4

0.26

1337

8897

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1156

7032

1.74

60.49

2.5

2.2

nmol/l

355.2

372.9

2.11

1074

6464

(3044640) Blood type and Crossmatch panel - Blood

2994

22770

1.47

59.95

2.6

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

842

4674

1.88

59.67

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1373

8799

1.66

59.08

2.8

2.5

21.9

23.2

2.59

1193

7581

(3021960) Folate [Moles/volume] in Serum or Plasma

2056

14568

1.53

57.65

1.7

1.5

nmol/l

19.7

20.7

2.51

1771

12601

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2384

17529

1.49

55.67

2.5

2.2

mg/l

2.7

2.8

2.31

2069

15046

(3014576) Chloride [Moles/volume] in Serum or Plasma

1185

7467

1.68

54.03

7.9

7.0

mmol/l

104.5

104.6

0.40

1157

7323

(3014133) Dog dander IgE Ab [Units/volume] in Serum

353

1454

2.49

53.77

1.1

u/ml

7.6

4.7

1.42

199

592

(3044889) 12 lead EKG panel

5503

47502

1.41

51.61

3.8

3.3

—

(4010399)

828

4781

1.81

51.39

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6348

56252

1.44

51.13

4.1

3.4

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

27.03

51.02

1.0

u/ml

0.2

0.0

—

(3013512) EKG study

2408

17997

1.46

50.89

4.0

3.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

941

5665

1.74

50.56

2.8

2.7

g/l

10.2

10.4

0.81

870

5209

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

619

3280

1.95

50.20

5.4

5.1

mmol/l

24.3

24.1

0.75

574

2983

(3023430) Cat dander IgE Ab [Units/volume] in Serum

327

1349

2.48

49.64

1.1

u/ml

6.7

5.7

0.36

202

581

(3002385) Erythrocyte distribution width [Ratio]

7025

63730

1.48

47.78

21.8

14.9

13.6

13.5

3.32

6946

62415

(3024354) Oxygen [Partial pressure] in Venous blood

806

4736

1.77

46.99

4.4

4.0

kpa

4.8

4.7

0.20

779

4588

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

733

4199

1.81

46.54

9.0

8.2

mmol/l

24.9

24.7

0.83

727

4174

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2300

17319

1.44

45.80

2.5

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1112

7183

1.63

45.45

18.8

20.8

inr

1.2

1.3

0.95

178

1107

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1083

6953

1.63

45.36

3.8

4.4

u/l

226.0

242.3

4.50

1025

6573

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8311

78605

1.82

45.02

12.6

9.5

u/l

26.3

25.9

1.23

8130

76049

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

870

5309

1.71

44.23

2.4

2.3

au/ml

21.2

24.0

0.24

349

(3019309) Folate [Moles/volume] in Red Blood Cells

1574

11071

1.51

44.11

1.9

1.7

nmol/l

1083.0

1173.4

3.72

1217

8477

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

637

3557

1.85

43.88

1.8

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

668

3793

1.82

43.58

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

3636

29816

1.37

43.32

2.1

2.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

105

6.61

43.23

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

18.96

43.10

1.1

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

742

4371

1.76

42.74

2.0

1.8

g/l

1.4

1.3

0.56

683

4036

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

285

1187

2.45

42.38

1.1

u/ml

0.9

0.3

0.91

117

280

(3009445) Proteinase 3 Ab [Units/volume] in Serum

524

2779

1.94

42.26

1.4

1.6

u/ml

8.3

12.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4151

34842

1.36

42.22

4.4

3.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1035

6706

1.61

41.55

2.7

2.9

1.8

1.7

0.15

919

5966

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

354

1635

2.21

41.44

2.1

2.2

g/l

0.0

0.54

338

1515

(3022145) Colonoscopy Study observation

1159

7719

1.58

41.41

1.3

—

(3000494) Fungus identified in Specimen by Culture

1219

8219

1.56

41.26

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

427

2145

2.04

40.17

2.1

2.2

g/l

7.2

7.4

1.04

357

1631

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

800

4894

1.70

40.14

1.3

au/ml

37.4

47.8

0.41

193

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

426

2142

2.04

39.97

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

2027

2.07

39.92

2.1

2.2

g/l

3.0

3.1

0.90

348

1596

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

425

2142

2.03

39.62

2.2

g/l

3.9

3.8

0.81

343

1550

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

380

1838

2.11

39.57

2.1

2.3

g/l

0.7

0.8

0.19

349

1609

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1235

8430

1.54

39.41

7.1

6.1

mmol/l

1.1

0.31

1178

7881

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

327

1493

2.24

39.37

2.2

g/l

0.0

0.00

316

1395

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

330

1513

2.23

39.33

2.2

g/l

0.0

0.43

315

1399

(40760892) CBC W Ordered Manual Differential panel - Blood

2254

17297

1.41

39.26

4.8

4.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6968

63802

1.42

39.03

5.9

5.0

mmol/mol

39.1

38.7

3.13

6517

59621

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

399

1986

2.06

38.49

2.2

g/l

10.1

10.3

0.34

363

1697

(3015171) Extractable nuclear Ab [Units/volume] in Serum

563

3150

1.84

38.43

1.3

u/ml

1.7

1.0

0.35

267

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

113

294

3.88

38.17

1.1

1.0

u/ml

12.3

6.4

0.62

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

351

1676

2.14

37.79

2.1

g/l

38.4

38.1

0.43

325

1467

(40761511) CBC panel - Blood by Automated count

8266

78535

1.70

37.58

15.9

11.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

305

1384

2.25

37.28

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

305

1384

2.25

37.28

1.4

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1587

11577

1.45

36.22

2.9

2.8

mmol/l

2.4

0.21

1384

10095

(3020630) Protein [Mass/volume] in Serum or Plasma

762

4727

1.67

36.14

2.6

2.5

g/l

67.0

66.7

0.43

715

4356

(3052851) Hemolysis interference index of Serum or Plasma

392

1988

2.02

35.91

3.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

511

2838

1.85

35.68

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

899

5838

1.60

35.46

4.5

4.3

0.8

0.9

0.67

259

1495

(3013139) Helicobacter pylori Ag [Presence] in Stool

794

5002

1.64

35.44

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

547

3116

1.80

35.16

1.4

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

424

2230

1.95

34.98

1.5

1.6

titre

211.8

328.6

0.62

100

(3021440) Promyelocytes/100 leukocytes in Blood

865

5586

1.61

34.90

4.5

4.3

0.1

0.2

1.02

240

1391

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

356

1764

2.06

34.76

1.4

1.5

iu/ml

20.1

14.5

0.27

(3004588) Protein electrophoresis panel - Serum or Plasma

634

3785

1.73

34.64

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1822

13727

1.41

34.60

2.5

2.2

—

(3009343) pH of Capillary blood

677

4116

1.70

34.60

4.9

4.3

7.4

0.16

499

(3002179) Metamyelocytes/100 leukocytes in Blood

835

5362

1.61

34.46

4.2

4.0

0.4

0.6

1.42

194

1106

(3003396) Base excess in Arterial blood by calculation

986

6586

1.56

34.39

8.4

7.3

mmol/l

0.8

0.9

0.55

792

5094

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1666

12376

1.43

34.22

2.4

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

587

3443

1.75

34.14

2.0

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

681

4166

1.69

34.00

4.9

4.3

kpa

5.2

5.1

1.14

643

3885

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

658

3990

1.70

33.95

4.8

4.3

mmol/l

1.8

1.6

1.29

494

2909

(3017958) Strawberry IgE Ab [Units/volume] in Serum

14.14

33.91

1.0

u/ml

0.3

0.1

0.50

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

388

2003

1.98

33.79

1.4

1.3

u/ml

11.3

9.5

0.14

326

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

953

6344

1.56

33.71

1.3

1.2

iu/ml

143.7

151.1

0.15

331

2433

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

414

2193

1.93

33.44

1.4

1.3

u/ml

29.7

38.4

0.30

148

(3007456) Orange IgE Ab [Units/volume] in Serum

12.84

33.13

1.0

u/ml

0.1

0.46

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

533

3084

1.77

32.47

10.8

9.5

mmol/l

24.3

24.2

0.24

511

2904

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7398

69027

1.42

32.46

4.6

4.0

mmol/l

5.9

5.8

6.23

6833

63748

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

380

1975

1.97

32.46

1.4

1.3

u/ml

5.6

6.1

0.07

200

(3027801) Oxygen [Partial pressure] in Arterial blood

978

6603

1.54

32.40

8.3

7.3

kpa

12.3

12.9

2.88

935

6297

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

978

6605

1.54

32.35

8.3

7.3

kpa

5.1

0.05

935

6299

(3016502) Oxygen saturation in Arterial blood

883

5835

1.57

32.19

8.7

7.8

95.3

95.9

1.57

855

5606

(3011397) Hemoglobin [Presence] in Urine by Test strip

2154

16864

1.37

32.06

3.9

3.4

—

(3009508) Creatinine [Moles/volume] in Urine

2506

20089

1.34

31.95

3.5

3.2

mmol/l

7.6

7.7

0.00

2082

17127

(3025159) Blasts/100 leukocytes in Blood

818

5320

1.59

31.92

4.5

4.3

0.0

0.3

1.55

204

1189

(3041096) Erythrocytes [Presence] in Urine by Automated

2525

20290

1.34

31.60

3.8

3.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

381

2006

1.94

31.33

2.6

2.4

ug/l

233.9

573.6

2.21

349

1861

(3002173) Hemoglobin [Mass/volume] in Arterial blood

827

5426

1.58

31.05

9.1

8.1

g/l

123.6

121.8

1.64

798

5216

(3000570) Elastase.pancreatic [Mass/mass] in Stool

368

1936

1.94

30.33

1.4

ug/g

299.4

288.0

0.44

184

1067

(3007461) Platelets [#/volume] in Blood

8666

84017

2.05

29.81

26.6

18.0

e9/l

263.3

258.7

8.86

8548

82024

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

433

2418

1.83

29.67

2.1

1.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

535

3179

1.73

29.65

10.4

9.9

—

(3025941) Bacteria identified in Stool by Culture

704

4500

1.61

29.46

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

771

5040

1.58

29.36

2.6

2.2

u/l

8983.8

6012.3

1.01

276

2013

(3023511) Choriogonadotropin [Units/volume] in Urine

458

2613

1.79

29.24

1.6

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

386

2089

1.89

29.21

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

816

5416

1.56

29.06

9.0

8.0

mmol/l

8.6

8.8

0.27

787

5203

(3023520) Reticulocytes [#/volume] in Blood

748

4872

1.58

28.91

2.7

2.8

e9/l

70.6

70.3

0.10

531

3605

(3035941) MCH [Entitic mass]

8667

84083

2.03

28.91

26.5

17.9

30.1

1.34

8613

83047

(3026361) Erythrocytes [#/volume] in Blood

8668

84097

2.03

28.90

26.6

18.0

e12/l

4.5

0.58

8530

81934

(3018001) Oat IgE Ab [Units/volume] in Serum

7.08

28.77

1.1

1.0

u/ml

3.0

0.1

0.51

(3000963) Hemoglobin [Mass/volume] in Blood

8669

84123

2.03

28.68

26.8

18.1

g/l

134.4

135.0

3.99

8618

83097

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1335

9807

1.42

28.66

2.0

1.7

1.5

1.4

3.09

1155

8759

(3024731) MCV [Entitic volume]

8666

84086

2.02

28.64

26.5

17.9

90.4

0.29

8613

83048

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

315

1603

2.00

28.59

1.3

u/ml

7.1

4.4

0.27

112

(3009542) Hematocrit [Volume Fraction] of Blood

7523

70738

1.40

28.58

19.5

13.1

39.8

0.22

5906

54771

(3010813) Leukocytes [#/volume] in Blood

8668

84124

2.02

28.44

26.7

18.0

e9/l

7.0

6.7

25.91

8528

81921

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

456

2625

1.78

28.24

3.7

3.2

0.7

0.06

442

2516

(36660697) Celiac disease serology panel - Serum

976

6773

1.50

28.19

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

272

1325

2.09

27.83

3.2

2.3

16.7

16.5

0.37

137

677

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

203

889

2.31

27.07

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

334

1770

1.92

26.95

1.2

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

584

3651

1.64

26.68

10.6

9.2

93.7

94.2

0.98

584

3636

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

494

2958

1.71

26.61

1.6

1.7

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

36.80

26.10

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

9.69

24.98

1.0

1.1

u/ml

0.0

0.1

0.70

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

212

979

2.19

24.92

1.2

1.3

nmol/l

0.5

1.7

0.55

200

949

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

704

4675

1.55

24.90

2.6

2.3

ug/l

4.7

7.2

5.45

606

4076

(40768443) Skin Pathology biopsy report

499

3058

1.67

24.63

1.2

—

(3012501) Base excess in Blood by calculation

277

1421

1.98

24.61

4.2

4.1

mmol/l

2.1

2.4

1.40

173

934

(3036489) Thrombin time

469

2829

1.69

24.57

2.3

2.6

20.8

21.4

1.66

417

2418

(3013290) Carbon dioxide [Partial pressure] in Blood

277

1422

1.98

24.56

4.2

4.1

kpa

5.0

0.10

272

1397

(3017143) Hepatitis C virus Ab [Presence] in Serum

1391

10544

1.38

24.50

1.7

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

384

2193

1.78

24.43

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

212

989

2.17

24.30

1.2

1.3

nmol/l

0.2

0.3

—

(3027315) Oxygen [Partial pressure] in Blood

277

1430

1.97

24.17

4.2

4.1

kpa

8.9

8.8

0.41

272

1404

(3010421) pH of Blood

309

1661

1.89

23.91

4.2

3.9

7.4

0.24

272

1397

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3281

28074

1.27

23.87

4.3

3.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2232

18199

1.30

23.84

4.4

4.0

mg/mmol

12.2

10.5

0.50

1385

11498

(42529406) Shigella sp [Presence] in Stool by Culture

383

2206

1.77

23.68

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

488

3004

1.66

23.67

1.9

u/l

39.0

39.2

0.10

453

2717

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

8.60

23.62

1.0

1.1

u/ml

0.0

0.1

0.55

(1616796) Gas panel - Central venous blood

276

1435

1.95

23.60

4.0

3.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

592

3832

1.58

23.40

1.7

1.6

mu/l

334.3

316.0

0.50

535

3444

(3028271) Lactate [Moles/volume] in Capillary blood

210

991

2.15

23.40

2.2

1.8

mmol/l

1.7

0.07

202

965

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

313

1703

1.87

23.33

1.3

u/ml

55.7

43.9

0.59

175

(3004119) Hemoglobin [Mass/volume] in Venous blood

549

3496

1.61

23.24

4.2

3.6

g/l

129.9

129.6

0.12

538

3411

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

458

2797

1.67

22.90

1.3

—

(3012516) Albumin [Mass/volume] in Urine

2135

17382

1.30

22.90

3.6

3.3

mg/l

333.5

403.1

0.30

1364

10879

(3028707) Methadone [Presence] in Urine by Screen method

325

1802

1.83

22.82

3.2

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

776

5360

1.49

22.74

4.1

3.7

mmol/l

1.2

1.61

673

4679

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

435

2626

1.69

22.73

1.8

g/l

1.5

0.64

379

2249

(3015235) Bicarbonate [Moles/volume] in Capillary blood

287

1540

1.89

22.34

3.9

3.5

mmol/l

24.7

24.6

0.17

256

1355

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

283

1513

1.90

22.28

3.3

3.7

57.8

56.8

0.69

283

1513

(3021901) Oxygen saturation in Capillary blood

220

1084

2.06

21.91

3.5

2.9

—

(3024928) Oxygen saturation in Venous blood

248

1278

1.97

21.78

3.4

4.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

680

4612

1.51

21.75

2.9

ng/l

152.2

166.9

0.47

604

4161

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

921

6634

1.43

21.66

3.8

3.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

242

1241

1.98

21.56

1.7

1.6

g/l

0.7

0.02

186

946

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

405

2435

1.69

21.49

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

370

2172

1.73

21.42

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

929

6719

1.43

21.35

1.5

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

323

1825

1.80

21.33

1.4

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

298

1644

1.84

21.28

2.2

2.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

187

876

2.16

21.27

1.8

1.5

iu/ml

41.7

30.2

0.42

(3000330) Specific gravity of Urine by Test strip

504

3217

1.60

21.12

3.5

3.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

751

5254

1.47

20.59

3.2

3.3

pmol/l

4.5

0.43

677

4720

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

283

1554

1.85

20.52

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

380

2276

1.70

20.45

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

298

2.97

19.84

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

378

2281

1.69

19.79

2.7

2.9

177.0

180.0

0.28

358

2163

(46235355) HIV 1 and 2 tests - Meaningful Use set

2316

19344

1.27

19.74

2.1

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7579

72211

1.33

19.55

4.8

4.3

mmol/l

2.8

2.04

7056

67325

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

860

6231

1.42

19.50

2.4

g/l

0.2

0.66

807

5834

(4062490)

169

791

2.16

19.30

1.7

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

303

1732

1.78

19.27

1.4

1.3

u/ml

266.8

254.7

0.31

192

1084

(3008898) HLA-B27 [Presence]

496

3231

1.57

19.05

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2166

18018

1.27

18.97

1.7

1.6

mmol/l

1.5

1.4

3.94

1833

15394

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

213

1096

1.97

18.84

1.7

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

325

1908

1.73

18.83

1.9

2.0

mg/l

10.9

0.01

310

1785

(44813793)

140

615

2.30

18.67

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

686

4806

1.46

18.63

4.7

4.0

ng/l

89.3

83.6

0.83

599

4188

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

210

3.30

18.63

1.2

1.1

—

(3002256) Pathology report gross observation

1197

9221

1.34

18.61

1.3

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

310

1803

1.75

18.57

6.2

4.9

kpa

8.6

8.8

1.23

289

1692

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

316

1856

1.73

18.29

1.8

1.7

—

(3045414) Leukocytes [Presence] in Urine

496

3265

1.55

18.19

2.0

1.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

196

994

1.99

18.09

1.3

u/ml

42.3

56.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

167

799

2.11

18.06

1.6

1.3

g/l

0.3

0.4

2.55

119

557

(3027135) IgG subclass 1 [Mass/volume] in Serum

167

799

2.11

18.06

1.6

1.3

g/l

6.4

6.6

0.23

120

561

(3028192) IgG subclass 2 [Mass/volume] in Serum

167

800

2.11

18.00

1.6

1.3

g/l

2.7

2.9

0.81

120

561

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

311

1827

1.73

17.99

3.7

4.3

u/ml

0.3

0.09

171

1021

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7189

68238

1.27

17.51

3.9

3.5

mmol/l

1.4

1.3

22.54

6661

63480

(3007700) Barley IgE Ab [Units/volume] in Serum

6.77

17.39

1.1

1.0

u/ml

40.7

0.9

0.48

(3035947) Staphylolysin Ab [Units/volume] in Serum

316

2.77

17.32

1.2

1.1

iu/ml

3.2

4.1

—

(3017732) Neutrophils [#/volume] in Blood

725

5218

1.42

17.01

2.7

2.6

e9/l

4.4

4.1

1.75

569

4214

(3035637) Corticotropin [Mass/volume] in Plasma

194

1003

1.95

16.97

1.7

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1699

13886

1.28

16.93

1.8

1.6

pmol/l

21493807.3

31108132.3

0.36

1433

11727

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7423

70819

1.28

16.82

4.4

3.9

mmol/l

1.4

1.5

27.40

6916

66190

(3019225) pH of Specimen

854

6335

1.38

16.80

4.2

4.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

305

1821

1.70

16.66

2.4

2.7

—

(40761536) Microorganisms panel - Urine sediment

870

6491

1.38

16.51

4.7

3.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

312

1880

1.68

16.47

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

501

3380

1.51

16.40

1.1

u/ml

47.7

3.6

—

(3007542) Rye IgE Ab [Units/volume] in Serum

6.10

16.36

1.1

1.0

u/ml

49.8

0.1

0.50

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

265

1530

1.75

16.33

1.7

—

(3011985) Renin [Units/volume] in Plasma

178

908

1.98

16.21

1.6

mu/l

63.8

63.0

0.02

163

806

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

127

570

2.25

16.16

1.1

1.2

titre

195.0

212.1

0.08

117

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7458

71292

1.28

15.98

4.4

3.9

mmol/l

4.7

5.91

6991

66886

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

318

1948

1.66

15.78

1.3

1.5

mg/l

496.9

484.5

0.07

307

1845

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

649

4644

1.43

15.71

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

176

905

1.96

15.68

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

173

886

1.97

15.59

1.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1089

8478

1.32

15.58

2.1

1.9

—

(3022313) Gas panel - Capillary blood

456

3050

1.52

15.56

5.2

4.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

380

2447

1.58

15.37

1.7

1.6

iu/ml

2.1

9.5

0.52

503

(40759836) Histone Ab [Presence] in Serum by Immunoblot

131

610

2.16

15.25

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

131

610

2.16

15.25

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

172

887

1.96

15.21

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

131

611

2.16

15.19

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

263

1548

1.72

15.17

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

878

1.95

14.97

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

131

617

2.14

14.83

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

131

617

2.14

14.83

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

170

881

1.95

14.83

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

131

618

2.14

14.77

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

164

841

1.97

14.75

1.4

pmol/l

302.7

359.7

0.68

137

663

(3005988) Vibrio sp identified in Specimen by Organism specific culture

170

883

1.94

14.73

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

267

1592

1.70

14.70

2.8

3.2

ratio

1.3

2.0

1.11

147

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

381

2483

1.56

14.64

2.8

3.2

94.1

92.8

0.51

361

2306

(3029937) Albumin [Presence] in Urine by Test strip

2251

19263

1.23

14.58

4.6

3.8

estimate

0.0

0.65

976

6871

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

360

2319

1.58

14.56

3.0

3.3

g/l

3.5

0.04

338

2191

(3027273) Bicarbonate [Moles/volume] in Venous blood

403

2668

1.53

14.43

4.6

3.3

mmol/l

25.1

25.2

0.51

393

2582

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

272

1642

1.68

14.31

2.9

3.3

mg/l

32.8

52.7

1.49

219

1335

(3023419) Bacteria identified in Sputum by Culture

146

727

2.03

14.28

2.3

3.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

223

1275

1.77

14.27

1.3

1.2

u/ml

3.5

3.4

0.05

424

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1266

10171

1.29

14.25

1.7

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

282

1724

1.66

14.14

1.2

1.5

mmol/l

3.6

3.7

0.79

269

1609

(3017354) Segmented neutrophils/100 leukocytes in Blood

126

597

2.13

14.08

2.9

3.2

62.2

56.7

1.88

391

(3024522) Salmonella sp identified in Specimen by Organism specific culture

169

891

1.91

14.03

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

271

1643

1.67

14.03

2.9

3.3

mg/l

54.3

84.7

0.42

218

1336

(3022621) pH of Urine by Test strip

635

4620

1.40

13.98

2.8

—

(3021788) Differential panel - Synovial fluid

203

1137

1.80

13.93

1.6

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

267

1618

1.67

13.85

1.3

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

147

743

1.99

13.81

1.9

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

632

4607

1.40

13.75

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

169

898

1.90

13.72

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

216

1239

1.76

13.69

1.3

1.2

u/ml

3.2

4.2

0.76

516

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

408

2743

1.51

13.61

5.5

4.6

mmol/l

25.0

24.6

2.46

385

2577

(3004809) Band form neutrophils/100 leukocytes in Blood

183

1002

1.84

13.53

3.3

1.0

1.4

1.55

131

796

(3030981) Hyaline casts [#/volume] in Urine by Automated count

467

3237

1.47

13.40

2.8

2.6

e6/l

0.2

0.3

0.34

450

3132

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

114

531

2.16

13.33

1.3

1.2

u/ml

12.7

13.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1885

15979

1.23

13.18

1.8

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

583

4224

1.41

13.15

1.1

titre

128.9

224.3

—

114

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

226

1332

1.71

13.03

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

332

2156

1.56

13.00

2.2

2.0

ug/l

1.3

2.2

1.76

286

1913

(3011288) Drugs identified in Urine by Screen method

425

2912

1.48

12.94

4.4

2.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

116

551

2.12

12.91

1.3

1.2

u/ml

67.1

58.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

313

2.51

12.85

3.6

2.4

umol/l

213.8

158.3

0.54

168

(3047007) Chlamydophila sp Ab [Presence] in Serum

215

1258

1.73

12.73

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

116

555

2.10

12.68

1.3

1.2

u/ml

47.3

41.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

114

542

2.12

12.67

3.5

4.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

120

582

2.08

12.66

1.4

1.5

promille

1.3

0.01

448

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

867

6726

1.32

12.62

1.9

1.8

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

141

726

1.96

12.60

2.9

3.2

nmol/l

5.4

12.4

0.44

133

705

(3020717) Zinc [Moles/volume] in Serum or Plasma

100

453

2.22

12.55

1.7

1.6

umol/l

19.1

23.6

1.05

433

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

396

2704

1.49

12.27

2.1

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

469

3311

1.44

12.23

2.7

2.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

222

1326

1.69

12.21

2.5

3.0

umol/l

32.8

35.0

0.74

192

1151

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

206

1206

1.72

12.20

1.8

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

465

2.19

12.19

1.7

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

256

1591

1.63

12.08

2.1

2.4

umol/l

8.0

6.5

0.33

182

1178

(4198724)

436

2.21

11.99

2.3

3.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

274

1735

1.60

11.98

1.5

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

273

1728

1.60

11.96

1.4

1.6

e6/l

3148.1

3176.3

0.00

226

1395

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

438

2.20

11.86

1.3

1.5

u/l

5.0

6.3

1.60

372

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

240

1482

1.64

11.64

6.2

5.8

iu/ml

797.2

644.9

0.10

186

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

271

1728

1.59

11.52

1.3

1.6

e6/l

19.6

25.8

0.37

212

1323

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

210

1256

1.69

11.52

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

400

2.24

11.42

1.1

u/ml

10.2

8.3

0.18

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

255

1617

1.59

11.11

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

461

3303

1.42

11.10

2.5

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

156

867

1.81

11.08

1.2

1.1

94.2

94.8

0.10

143

815

(3037756) Immunofixation for Serum or Plasma

179

1042

1.73

10.87

1.9

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

111

555

2.01

10.85

1.6

1.3

nmol/l

1.7

1.4

1.54

499

(1002224) Polysomnography panel

447

3207

1.41

10.69

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

208

1268

1.66

10.65

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

199

1201

1.67

10.59

1.1

120.4

116.2

0.99

177

1083

(3042517) Benzodiazepines panel - Urine

105

3.44

10.53

2.8

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

267

1734

1.56

10.52

1.5

1.4

u/ml

8.9

21.4

—

(3049717) Cytology report of Urine Cyto stain

280

1849

1.53

10.24

2.6

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

175

1031

1.71

10.20

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

234

1486

1.59

10.17

1.6

e6/l

15903.3

11257.0

0.53

151

1070

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

153

872

1.77

10.03

1.1

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

228

1444

1.59

10.03

2.8

2.1

g/l

130.5

129.8

0.17

168

1052

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

251

1627

1.56

10.00

1.6

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

203

1251

1.64

9.99

1.1

—

(3044941) Cell count panel - Synovial fluid

168

985

1.72

9.98

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

576

4358

1.34

9.95

2.7

2.0

—

(3016879) Cocaine [Presence] in Urine

531

3969

1.36

9.94

2.8

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

672

5201

1.32

9.92

1.4

iu/l

23.7

26.1

1.12

562

4443

(3003338) MCHC [Mass/volume]

6872

65918

1.18

9.91

22.7

15.4

g/l

332.2

332.6

3.13

6841

65427

(3036071) Salmonella sp Ab [Titer] in Serum

278

2.38

9.90

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

204

1263

1.63

9.86

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

126

681

1.86

9.84

1.9

2.5

43.5

43.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

179

1074

1.68

9.77

1.2

—

(3027008) Opiates [Presence] in Urine

573

4348

1.34

9.71

2.7

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

188

1145

1.66

9.70

4.0

3.4

u/ml

371.4

1285.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

107

551

1.95

9.67

1.8

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

569

4318

1.34

9.64

2.7

2.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

4.18

9.61

1.3

1.4

ug/l

130.8

124.8

0.07

(3035320) C reactive protein [Mass/volume] in Body fluid

104

532

1.97

9.59

3.3

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

190

1165

1.64

9.56

1.5

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

134

748

1.80

9.45

2.0

2.6

nmol/l

23.9

19.7

3.03

128

714

(3033705) Calcium.ionized [Moles/volume] in Venous blood

116

621

1.88

9.35

3.2

2.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

3.41

9.29

1.2

1.3

—

97.6

—

(3019060) Gas panel - Arterial blood

494

3692

1.36

9.27

4.5

4.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

2472

1.43

9.18

2.0

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

245

1615

1.53

9.09

1.6

1.5

u/ml

120.5

111.1

0.29

328

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

125

692

1.82

9.08

1.3

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

232

1514

1.55

9.01

1.4

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

441

2.03

9.00

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

205

1302

1.59

8.96

3.4

2.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

137

783

1.76

8.95

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

148

866

1.72

8.90

1.3

1.7

—

(4306422)

199

1257

1.60

8.90

1.2

—

(3027944) Amphetamines [Presence] in Urine

559

4287

1.32

8.83

2.5

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

330

2328

1.43

8.73

5.1

5.2

0.9

0.07

309

2165

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

299

2072

1.46

8.70

1.8

1.9

iu/l

3.0

4.5

4.47

107

813

(3051611) Lipemic interference index of Serum or Plasma

118

652

1.82

8.65

3.7

3.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

1126

1.62

8.64

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

518

1.92

8.59

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

518

1.92

8.59

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

518

1.92

8.59

1.4

1.6

—

(3011412) CD3 cells [#/volume] in Blood

138

802

1.73

8.53

2.1

2.6

e9/l

1.4

1.2

1.48

475

(3017315) Amylase [Enzymatic activity/volume] in Urine

356

2.12

8.52

1.5

1.2

u/l

233.0

285.9

0.39

328

(3045142) Bone marrow Pathology biopsy report

122

685

1.79

8.49

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

226

1487

1.53

8.48

1.1

—

(3011648) Oxygen content in Venous blood

100

528

1.90

8.45

2.4

4.8

10.8

11.3

0.48

100

528

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

610

1.83

8.30

1.9

2.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

225

1487

1.53

8.28

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

295

2063

1.44

8.21

1.3

titre

984.4

1038.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

280

2.22

8.00

1.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

296

2085

1.43

7.93

1.3

titre

136.7

126.9

0.08

194

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

213

1411

1.52

7.78

1.2

1.1

au/ml

8.9

11.0

0.23

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

121

698

1.74

7.72

1.1

—

(3023410) Appearance of Cerebral spinal fluid

139

838

1.67

7.56

1.4

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

325

2351

1.40

7.51

5.0

5.1

1.7

0.45

304

2182

(3009466) Valproate [Moles/volume] in Serum or Plasma

162

1020

1.60

7.42

5.3

umol/l

358.0

372.3

0.69

136

883

(21491868) Cryoglobulin [Mass/volume] in Serum

264

2.20

7.37

1.3

1.2

g/l

0.1

0.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

311

2.10

7.30

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

749

6109

1.25

7.29

3.7

3.9

ug/l

22.4

29.2

0.20

581

4767

(40760888) Immunoglobulin light chains.free panel - Serum

187

1224

1.54

7.25

3.0

3.3

—

(3037121) Protein [Mass/volume] in Urine

321

2333

1.39

7.23

3.4

3.3

g/l

0.3

0.4

1.64

152

1015

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

151

942

1.61

7.20

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

270

1907

1.43

7.17

5.2

5.9

mmol/l

1.4

1.3

1.00

243

1661

(3008152) Bicarbonate [Moles/volume] in Arterial blood

460

3539

1.32

7.15

7.1

6.8

mmol/l

24.5

0.07

430

3284

(3036603) Volume of Urine

416

1.93

7.15

1.5

1.6

2159.9

2070.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

204

1366

1.50

7.12

2.4

2.1

nmol/l

1.0

0.8

1.43

164

1160

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

153

961

1.60

7.10

1.1

g/l

1.5

0.61

147

860

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

101

568

1.79

7.07

1.3

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

146

909

1.62

7.03

1.2

1.1

iu/ml

1.7

2.3

—

(3006653) Thiamine [Moles/volume] in Blood

343

2.02

7.01

1.4

nmol/l

139.4

132.8

0.62

343

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.85

6.97

2.3

1.5

umol/l

46.0

43.1

0.13

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

128

773

1.67

6.95

6.3

7.1

mg/l

10.6

11.4

0.94

122

723

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

100

566

1.78

6.86

1.3

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

111

649

1.72

6.81

1.9

2.3

11.1

12.8

1.05

352

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

104

598

1.75

6.77

1.3

1.4

mmol/l

1.7

2.0

3.01

561

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

201

1358

1.49

6.75

1.6

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

362

1.97

6.74

1.6

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

121

2.73

6.68

1.1

umol/24h

0.6

0.7

0.74

(3006442) Creatine [Moles/volume] in Serum or Plasma

462

1.85

6.67

1.5

1.4

umol/l

61.2

67.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

256

2.16

6.66

3.9

4.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

289

2095

1.39

6.65

3.3

3.5

u/ml

1024.0

2509.9

0.48

251

1783

(21494890) Protein electrophoresis panel - 24 hour Urine

521

1.79

6.62

2.0

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

193

1302

1.49

6.54

1.1

u/ml

4.3

3.1

0.42

643

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

140

2.58

6.51

1.4

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

543

4330

1.27

6.44

2.3

2.1

nmol/l

10.3

11.6

2.96

473

3809

(3019150) Specific gravity of Urine by Refractometry

1760

15669

1.15

6.43

4.3

3.7

kg/l

1.0

0.16

257

2351

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

950

8044

1.20

6.41

4.3

4.0

31.9

32.4

0.76

713

5621

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

876

1.60

6.41

1.7

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

309

2.01

6.30

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

309

2.01

6.30

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

309

2.01

6.30

1.5

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

323

2407

1.35

6.28

1.1

u/ml

4.3

6.3

0.62

331

(4094501)

235

1661

1.43

6.27

1.1

—

(3003181) Sodium [Moles/volume] in Urine

158

1032

1.54

6.25

1.8

1.5

mmol/l

58.0

63.8

1.04

128

827

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

310

2.01

6.25

1.5

1.8

—

(3003694) ABO and Rh group [Type] in Blood

2537

23193

1.13

6.20

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

284

2.05

6.19

2.0

2.2

mg/l

8.7

9.8

0.69

238

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

100

585

1.72

6.16

1.1

iu/ml

9.0

9.7

0.07

144

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

573

1.72

6.06

1.2

1.3

—

(4268621)

136

865

1.58

6.06

2.6

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

113

687

1.65

6.04

1.3

1.4

titre

—

(4024509)

108

649

1.67

6.04

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

391

1.87

6.04

1.4

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

115

704

1.64

5.99

3.7

3.8

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

531

1.74

5.96

12.1

11.3

mmol/l

0.6

0.90

482

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

124

779

1.60

5.83

2.3

2.1

mg/l

21.8

24.8

0.24

204

(3028679) Herpes simplex virus Ab [Presence] in Serum

498

1.75

5.81

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

172

1164

1.49

5.79

1.3

—

(3045716) Anion gap in Serum or Plasma

259

2.05

5.71

2.9

2.3

mmol/l

8.7

9.2

0.50

204

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

104

629

1.66

5.70

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

180

1234

1.47

5.69

1.1

iu/ml

57.6

8579.2

0.64

315

(3029075) Extractable nuclear Ab panel - Serum

233

2.11

5.68

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

429

1.80

5.65

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

593

1.68

5.63

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.70

5.63

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

109

671

1.63

5.59

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

268

1982

1.36

5.52

4.6

3.8

mmol/l

1.4

0.12

263

1944

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

128

2.51

5.51

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

2.29

5.51

4.6

2.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

171

2.29

5.51

1.5

1.3

nmol/l

115.9

114.8

0.02

122

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

2.29

5.51

4.5

2.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

318

1.92

5.51

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

118

747

1.59

5.41

1.5

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

300

1.94

5.37

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

300

1.94

5.37

1.2

1.3

—

(44790047)

125

804

1.56

5.36

1.8

1.6

—

(44806118)

125

804

1.56

5.36

1.8

1.6

—

(44790049)

125

804

1.56

5.36

1.8

1.6

—

(44790048)

125

804

1.56

5.36

1.8

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

220

2.10

5.28

2.2

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

325

1.88

5.18

1.7

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

102

631

1.62

5.16

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

106

663

1.61

5.13

1.5

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

495

1.70

5.12

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

171

2.23

5.08

1.1

—

205.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

196

1397

1.41

5.07

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

110

2.55

5.03

1.2

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

410

1.76

4.96

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

500

1.69

4.95

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

200

1442

1.40

4.86

4.6

4.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

544

1.64

4.75

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

575

1.62

4.75

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

238

1.98

4.67

4.8

4.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

118

776

1.53

4.64

1.3

1.4

mmol/l

10.5

11.9

0.86

144

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

295

1.87

4.62

1.1

1.2

89.1

90.8

0.11

131

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

557

1.62

4.59

2.0

2.8

e6/l

783.7

770.9

0.05

226

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

115

756

1.53

4.54

1.5

1.6

53.5

55.3

0.17

472

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

575

1.61

4.52

1.1

1.0

mg/l

284.0

293.3

0.68

518

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

2.21

4.51

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

2.21

4.51

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

2.21

4.51

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

2.21

4.51

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

291

1.86

4.48

2.1

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

186

1345

1.39

4.48

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.53

4.45

3.5

2.6

—

(4035726)

690

5875

1.19

4.42

1.5

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

440

1.69

4.42

1.1

nmol/l

0.8

9.1

1.31

(3014148) Varicella zoster virus Ab [Titer] in Serum

177

1275

1.40

4.37

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

149

1042

1.44

4.35

2.4

2.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

144

2.23

4.32

1.3

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

302

1.83

4.32

1.1

92.3

91.6

0.06

131

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

140

969

1.45

4.32

1.2

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

710

1.53

4.29

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

260

1.89

4.28

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

607

1.57

4.28

2.0

2.7

e6/l

524.8

519.4

0.04

492

(3020891) Body temperature

294

2294

1.29

4.26

5.6

4.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

109

719

1.52

4.26

1.2

1.1

mg/l

32.9

38.6

1.06

604

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

318

1.80

4.26

2.0

2.9

ug/l

0.9

1.4

1.20

299

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

106

697

1.53

4.21

1.1

mg/l

217.0

239.1

0.71

613

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

199

2.01

4.21

1.6

1.5

ug/l

10.4

8.7

0.88

199

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

104

682

1.53

4.18

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.74

4.17

2.9

3.0

mg/l

1.2

1.4

0.12

(3051651) Icteric interference index of Serum or Plasma

410

1.69

4.15

4.3

3.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

285

1.83

4.13

2.5

2.1

ug/min

11.2

123.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

293

1.81

4.09

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

481

1.63

4.08

1.6

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

222

1678

1.33

4.07

4.4

4.0

mmol/l

3.8

3.9

0.67

204

1577

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

323

1.77

4.06

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

592

1.56

4.04

2.0

2.8

e9/l

0.2

0.53

490

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

420

3442

1.23

4.03

1.3

miu/ml

211.1

227.7

0.44

197

1669

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1066

9459

1.14

4.02

1.9

—

(3008295) Osmolality of Serum or Plasma

105

697

1.51

4.01

1.6

1.5

mosm/kgh2o

280.2

281.1

0.13

540

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.93

3.97

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

588

1.55

3.94

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

319

1.76

3.93

1.4

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

171

2.05

3.89

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

151

2.12

3.88

1.2

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.17

3.88

1.1

1.2

g/l

0.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

165

1203

1.38

3.84

1.9

pmol/l

176.3

187.2

0.52

154

1138

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

389

1.68

3.84

1.2

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.42

3.79

1.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

538

1.57

3.79

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.53

3.79

1.5

1.6

mg/l

0.6

2.0

1.97

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.48

3.79

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

136

962

1.42

3.78

1.6

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

399

1.66

3.76

1.2

1.3

—

(3042631) Mycobacterium sp identified in Specimen

109

740

1.48

3.76

2.7

2.8

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

194

1.96

3.76

1.1

67.7

68.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

251

1.84

3.73

1.1

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

618

5294

1.18

3.73

3.1

2.5

ml/min/173m2

68.5

71.6

0.99

235

2026

(40761535) Cells panel - Urine sediment

616

5276

1.18

3.72

4.2

3.4

—

(21494755) Public health laboratory ask at order entry panel

784

8943

0.86

3.68

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

251

1961

1.29

3.66

5.7

5.8

mg/l

1.5

1.4

1.33

232

1831

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

237

1838

1.30

3.66

1.8

1.7

nmol/l

37.5

42.1

2.24

231

1787

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

418

1.63

3.65

1.6

1.4

u/ml

32.3

19.6

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

2.0

1.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

4.0

1.8

0.49

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

0.3

1.3

2.37

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

0.8

2.7

2.00

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

0.7

1.6

0.83

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

0.6

2.1

2.09

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

1.2

1.7

0.47

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

2.7

4.2

0.70

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.54

3.62

1.5

1.6

mg/l

2.0

3.3

0.53

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

633

1.51

3.61

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1314

11897

1.12

3.60

1.7

—

(40768795) Lymph node Pathology biopsy report

102

691

1.48

3.58

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

270

1.78

3.55

2.5

—

(3019977) pH of Arterial blood

307

1.73

3.55

4.8

2.9

7.4

0.34

104

(40768446) Kidney Pathology biopsy report

286

1.75

3.50

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

170

1266

1.35

3.50

1.7

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

2.14

3.50

7.0

6.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

880

7785

1.14

3.48

2.9

ug/l

0.7

1.84

581

4955

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1476

13487

1.11

3.43

4.7

4.6

ug/l

2.2

2.6

0.57

1321

12138

(4015189)

139

2.09

3.42

2.2

2.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

281

1.75

3.41

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.98

3.40

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

163

1212

1.35

3.40

1.6

1.5

—

(40768441) Liver Pathology biopsy report

529

1.54

3.40

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

195

1.90

3.37

1.1

94.6

80.9

—

(3000060) B lymphocytes [#/volume] in Blood

305

1.71

3.35

1.6

2.6

e6/l

253.1

243.1

0.08

167

(3017400) Magnesium [Moles/volume] in Urine

5.72

3.34

1.4

1.9

mmol/l

3.1

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

549

1.52

3.29

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.41

3.29

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

395

3291

1.21

3.28

1.6

mg/l

4.6

3.7

0.77

288

2277

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

255

1.77

3.28

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

220

1719

1.29

3.25

1.3

1.2

—

(4027681)

567

1.50

3.25

1.3

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

205

1.86

3.24

1.1

1.2

104.0

106.0

0.18

192

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

272

1.73

3.19

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

481

1.54

3.19

1.6

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

192

1.88

3.18

2.4

2.1

umol/l

12.0

16.4

2.22

192

(3009871) Measles virus Ab [Titer] in Serum

280

1.72

3.17

1.9

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.96

3.13

1.5

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.41

3.13

8.7

12.2

mmol/l

5.4

5.6

0.09

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

565

1.49

3.10

1.6

1.5

30.2

33.8

0.38

343

(3024932) HLA-DR beta [Type]

253

1.74

3.07

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

239

1.76

3.04

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

174

1.90

3.03

1.2

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.84

3.02

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

233

1.76

2.99

1.8

1.7

au/ml

319.6

111.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

355

1.61

2.97

1.5

1.7

mmol/24h

6.6

6.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

103

728

1.42

2.96

4.7

5.0

mmol/l

8.1

7.1

0.33

595

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

169

1.90

2.94

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

169

1.90

2.94

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

169

1.90

2.94

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

516

1.50

2.92

1.6

1.4

e6/l

22833.7

74637.7

2.03

304

(3012565) Volume of 24 hour Urine

349

1.61

2.92

2.2

2179.5

1991.0

0.58

320

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.83

2.91

1.3

1.2

—

(3016750) Collection duration of Urine

334

1.62

2.90

2.0

2.2

min

515.4

495.8

0.63

256

(3024471) HLA-A [Type]

258

1.71

2.89

1.0

—

(3044927) Protein electrophoresis panel - Urine

535

1.48

2.85

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

143

1.96

2.84

1.4

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.34

2.81

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

203

2552

0.79

2.80

1.4

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

546

1.47

2.79

1.3

1.4

umol/l

11.2

11.6

0.23

521

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

112

813

1.38

2.79

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.92

2.77

1.0

1.1

—

(3039000) Anion gap in Blood

171

1324

1.30

2.77

6.1

7.0

mmol/l

11.3

11.2

0.12

153

1174

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

239

1.72

2.76

3.5

2.7

—

(3030313) Adrenal Ab [Titer] in Serum

2.17

2.76

1.3

1.1

—

(3018572) Chloride [Moles/volume] in Blood

171

1325

1.30

2.75

6.1

7.0

mmol/l

105.3

0.02

153

1175

(3020491) Glucose [Moles/volume] in Blood

565

1.46

2.73

1.6

2.0

mmol/l

6.6

6.3

0.44

417

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

379

1.56

2.73

1.5

1.6

nmol/l

2.0

4.6

1.19

306

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.28

2.67

1.7

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

479

1.49

2.64

1.8

mg/l

2.8

3.9

4.05

464

(3009214) Lutropin [Units/volume] in Serum or Plasma

338

2843

1.20

2.61

1.5

1.4

u/l

10.5

10.0

0.27

274

2301

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

630

1.42

2.59

1.3

umol/l

4.3

5.5

2.61

587

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

174

1364

1.28

2.58

2.4

ug/min

147.4

86.8

0.90

104

839

(3004775) Volume in Urine collected for unspecified duration

442

1.50

2.55

2.3

758.6

614.3

0.83

306

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

410

1.52

2.55

1.3

1.2

u/l

70.6

87.4

1.27

363

(3050129) First trimester maternal screen panel - Serum or Plasma

386

4509

0.85

2.55

1.5

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

193

1.76

2.53

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.27

2.50

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

240

1.67

2.46

1.5

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

240

1.67

2.46

1.5

2.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

398

1.51

2.44

1.3

1.2

u/l

15.5

20.8

0.78

346

(3023199) Leukocytes [#/volume] in Pleural fluid

579

1.42

2.44

1.6

1.4

e6/l

1365.4

2410.9

2.08

425

(3009677) Dengue virus Ab [Presence] in Serum

2.94

2.41

1.0

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

115

861

1.34

2.41

3.1

nmol/l

0.9

0.8

0.51

647

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

321

1.56

2.36

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

104

2.02

2.35

1.3

ng/l

114.0

59.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.31

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

237

1.65

2.31

2.3

2.6

umol/l

28.1

27.7

0.08

170

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

245

1.64

2.30

1.5

1.9

—

(3004451) EKG impression Narrative

269

1.60

2.28

1.4

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

270

1.60

2.25

4.3

2.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

156

1.80

2.24

1.6

3.7

mmol/l

1.2

1.89

146

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

505

4448

1.14

2.23

3.0

3.2

u/ml

35.8

46.0

1.15

488

4300

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

440

1.46

2.22

2.1

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

273

3241

0.84

2.22

1.6

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.34

2.21

1.1

umol/24h

1.9

1.6

0.54

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

295

1.56

2.21

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

294

3465

0.84

2.20

1.4

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

122

938

1.30

2.16

2.9

2.6

u/ml

354.1

661.6

0.30

117

863

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.29

2.15

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

115

1.92

2.15

2.0

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

436

1.45

2.13

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.05

2.10

2.6

2.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

168

1.73

2.07

1.2

pmol/l

303.4

287.5

0.07

120

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

206

1.65

2.06

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

440

1.43

2.04

1.3

1.4

pmol/l

58.6

124.4

0.50

144

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

424

1.44

2.03

1.1

u/ml

2.6

16.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

326

1.51

2.02

2.8

3.0

au/ml

160.6

140.8

—

(3019174) dRVVT (LA screen)

2.11

2.02

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

253

2988

0.84

1.98

1.9

1.8

—

(40768806) Pleura Pathology biopsy report

502

1.40

1.97

1.6

1.5

—

(3028433) Virus identified in Specimen by Culture

248

1.58

1.97

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

119

1.85

1.96

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

2.03

1.95

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

428

1.43

1.94

1.2

1.1

miu/ml

1485.5

1467.9

0.04

428

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

179

1.68

1.94

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.73

1.93

1.2

2.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

290

1.52

1.91

1.1

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.24

1.90

1.0

1.2

—

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1713

16172

1.07

1.89

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.65

1.86

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

284

1.52

1.86

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.50

1.83

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.83

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

198

1.62

1.82

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

510

1.38

1.82

1.4

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

536

1.36

1.81

1.2

1.1

ratio

1.1

0.58

188

(3024869) Neuronal Ab [Presence] in Serum

108

1.85

1.81

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

130

1.77

1.81

1.1

1.2

mg/l

0.5

102.9

1.21

(3015183) Erythrocyte sedimentation rate

460

1.39

1.81

1.3

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.05

1.79

1.0

7.4

8.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.05

1.79

1.3

1.0

19.0

20.8

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.05

1.79

1.3

1.0

37.9

37.0

—

(21494434) Karyotype in Bone marrow

520

1.37

1.79

1.2

—

(3045788) Cell count panel - Pleural fluid

461

1.39

1.79

1.7

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

337

1.46

1.76

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

626

1.33

1.75

1.6

1.5

g/l

33.4

0.01

567

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

498

1.37

1.73

1.1

u/l

1.0

1.1

0.14

213

(3007919) Fasciola sp Ab [Titer] in Serum

3.85

1.71

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1148

10722

1.08

1.70

3.9

4.0

22.1

21.6

0.45

493

4912

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

629

1.32

1.70

1.2

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

226

1.55

1.69

3.3

2.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

458

1.38

1.68

1.6

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

146

1190

1.23

1.67

2.7

3.4

u/ml

352.9

541.5

0.31

132

1087

(3002619) Bacteria identified in Specimen by Culture

149

1.68

1.66

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.16

1.66

1.0

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

729

7939

0.91

1.66

7.8

5.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

204

1.57

1.64

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

165

1.64

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

112

1.79

1.64

2.0

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

152

1248

1.22

1.63

3.9

3.8

u/ml

32.9

29.2

0.15

145

1211

(3007463) Buprenorphine [Presence] in Urine

2.33

1.60

10.2

5.1

—

(3014891) Appearance of Pleural fluid

2.07

1.59

1.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

1.59

1.0

1.1

—

(3024263) Appearance of Synovial fluid

329

1.43

1.57

1.6

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

717

1.29

1.56

1.2

u/l

55.2

67.4

0.99

496

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

152

1.65

1.56

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.43

1.53

3.8

3.0

—

(3032057) Clostridioides difficile [Presence] in Stool

130

1.69

1.52

1.4

1.9

—

(3017704) Immunofixation for Urine

290

1.45

1.52

1.8

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

476

1.35

1.51

1.2

—

(3006462) Nitrate [Presence] in Urine

361

1.39

1.43

2.4

2.9

—

(4146454)

603

1.30

1.43

2.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

125

1.68

1.43

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

353

1.39

1.42

2.2

1.6

iu/ml

3128125.2

2110287.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

551

1.31

1.42

1.3

1.4

e6/l

83985.5

80117.2

0.02

381

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

141

1.63

1.41

2.5

2.4

mmol/l

1.3

1.7

0.38

103

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.82

1.41

3.5

3.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

415

1.35

1.38

1.3

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.61

1.36

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

104

1.73

1.36

3.7

2.5

ml/dl

15.6

14.7

0.53

(3020393) Adenovirus Ag [Presence] in Stool

135

1.63

1.35

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

298

1.41

1.34

1.5

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.87

1.34

1.7

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.87

1.34

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.91

1.33

1.2

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

208

1.49

1.32

1.2

1.1

u/ml

49.3

53.2

0.14

200

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

113

1.68

1.31

2.2

3.1

mg/l

112.7

18.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.81

1.31

1.7

1.9

—

(3029612) Listeria sp Ab [Titer] in Serum

2.50

1.30

1.7

1.3

—

(3047189) Immunofixation for 24 hour Urine

250

1.44

1.30

2.5

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

201

1.49

1.29

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.76

1.28

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

227

1.46

1.26

2.2

11.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

138

1.60

1.25

1.6

1.5

—

(3048879) Bone marrow aspiration report

146

1.58

1.25

1.3

2.1

—

(3000012) Reticulocyte production index

328

1.37

1.25

1.9

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

170

1.53

1.25

1.3

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

131

1.60

1.23

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

220

1.46

1.23

2.0

1.4

—

(3016038) Potassium [Moles/volume] in Urine

408

1.33

1.21

2.4

1.4

mmol/l

36.3

35.0

0.13

359

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.72

1.21

1.4

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

140

1.57

1.19

1.6

2.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

289

1.39

1.18

2.6

6.3

mg/l

83.5

67.1

0.68

220

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.31

1.18

1.3

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

165

1.52

1.17

1.1

1.2

g/l

37.6

38.5

0.10

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

102

1.67

1.16

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

199

1.46

1.14

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

326

1.35

1.13

1.4

1.3

u/l

12.6

12.0

0.11

302

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

582

1.26

1.11

2.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

354

1.33

1.09

24.9

28.0

ug/l

149.0

118.8

1.52

300

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

354

1.33

1.09

3.6

3.5

mg/l

8.5

8.1

0.19

278

(3052592) Norovirus Ag [Presence] in Stool

112

1.61

1.08

1.2

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

329

1.34

1.08

3.6

3.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.19

1.08

9.4

4.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

196

1718

1.14

1.07

1.6

1.5

nmol/l

0.5

0.4

0.19

142

1371

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.92

1.06

4.7

5.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.12

1.05

6.9

7.8

—

(4211845)

393

1.30

1.03

2.4

2.9

—

(3050794) Legionella sp Ab [Presence] in Serum

1.83

1.02

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

106

1.60

1.02

1.5

1.2

—

(3025130) Human papilloma virus identified in Specimen

163

1417

1.15

1.02

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

789

1.21

1.01

4.0

4.7

u/ml

41.9

74.7

1.16

242

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.65

1.00

4.3

5.7

ug/min

35.9

42.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

391

0.72

0.99

1.4

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.17

0.98

1.6

1.2

nmol/l

258.8

333.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

232

1.38

0.97

2.9

3.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.80

0.96

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.80

0.96

5.0

—

(3017569) Oxygen content in Arterial blood

250

1.36

0.95

3.4

2.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

355

1.30

0.94

1.3

1.8

nmol/l

1.2

1.3

0.23

280

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

408

1.28

0.94

2.0

2.6

45.2

41.0

0.82

146

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.89

0.94

1.3

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.22

0.93

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

102

1.57

0.90

2.8

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

402

1.27

0.90

1.2

1.3

62.2

68.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

349

1.29

0.89

1.7

1.6

u/field

2.0

3.2

0.79

241

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

429

1.26

0.89

1.7

1.6

u/l

7.0

5.1

0.32

216

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

743

7860

0.94

0.89

1.7

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

185

1.41

0.89

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

202

1.39

0.89

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.69

0.88

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

147

1677

0.87

0.88

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.65

0.87

2.7

3.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

181

1608

1.13

0.86

1.4

u/l

22.6

24.4

0.31

153

1329

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.94

0.84

15.2

10.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

309

1.30

0.83

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

292

1.30

0.82

1.2

1.1

ng/l

71.0

368.0

—

(40768793) Breast Pathology biopsy report

205

1844

1.11

0.80

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

645

1.20

0.80

1.3

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

276

1.31

0.80

4.7

3.5

—

(3020650) Glucose [Presence] in Urine

224

1.34

0.79

1.5

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

497

0.78

1.8

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.78

2.0

2.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.77

0.0

8.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

122

1069

1.14

0.75

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.84

0.73

1.0

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

509

5401

0.94

0.71

1.4

—

(3025315) Body weight

1.58

0.71

6.3

3.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.58

0.71

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.71

0.70

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.53

0.68

1.8

1.6

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.56

0.68

2.1

2.6

mg/l

3.4

3.3

0.03

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

929

1.14

0.67

1.6

1.3

u/l

48.4

35.5

0.27

801

(3006270) Folate [Moles/volume] in Blood

557

1.19

0.67

1.1

nmol/l

364.5

389.4

0.50

499

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.63

0.66

7.1

1.8

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

179

1.34

0.66

2.2

1.5

nmol/l

0.2

0.59

126

(40757373) Influenza virus identified in Isolate

136

1.40

0.66

2.0

1.6

—

(44806420)

128

1.41

0.65

3.1

2.3

—

(3014271) Vancomycin [Susceptibility]

259

1.28

0.65

3.0

2.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

189

1.32

0.64

1.8

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

903

0.86

0.63

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

323

1.24

0.63

1.2

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

323

1.24

0.63

1.2

2.0

—

(37021550) Renin [Units/volume] in Plasma --upright

155

1.36

0.62

1.2

1.3

mu/l

133.4

58.3

0.31

121

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.52

0.62

9.6

7.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

104

1.44

0.62

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

102

0.59

0.62

8.5

6.5

81.8

71.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.59

0.61

1.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.60

0.0

1.2

—

4640.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

105

1.43

0.60

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.54

0.59

11.0

5.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

399

1.20

0.59

1.0

95.5

91.2

0.35

315

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

547

1.17

0.58

1.5

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

210

1.29

0.58

6.5

3.8

49.5

51.6

0.20

202

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

158

1.33

0.57

2.2

1.6

ug/l

0.4

0.05

102

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.56

2.2

4.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

176

1.31

0.56

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

497

1.17

0.53

1.9

u/field

2.1

1.9

0.14

207

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

372

3513

1.06

0.53

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.43

0.52

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.43

0.52

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

143

1.33

0.52

10.7

7.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

372

3516

1.06

0.52

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.50

0.51

1.2

1.1

mmol/l

7.3

8.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

1.38

0.50

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.46

0.50

1.3

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

397

3765

1.06

0.50

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

369

3493

1.06

0.49

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

370

3504

1.06

0.49

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

648

6737

0.96

0.47

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

102

1.37

0.47

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

299

2822

1.06

0.46

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.43

0.45

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

741

1.12

0.45

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

157

1.27

0.43

10.3

7.2

—

(3005033) Fetal Nuchal fold Thickness US

297

2811

1.06

0.42

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

162

0.74

0.42

1.0

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.56

0.42

1.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.42

1.8

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.52

0.41

1.0

1.1

mg/l

0.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

1.32

0.40

1.3

1.2

ug/l

71.4

418.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

1.25

0.40

1.0

1.1

—

(3034426) Prothrombin time (PT)

287

1.19

0.40

1.3

1.2

—

(3032641) Amino acids panel - Urine

0.00

0.39

0.0

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.36

0.38

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

335

1.16

0.38

3.1

2.4

umol/l

19.1

67.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

258

0.81

0.38

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

170

1.24

0.37

2.1

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

526

5073

1.04

0.37

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

333

3181

1.05

0.36

1.9

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

332

0.84

0.36

6.4

5.7

u/ml

128.8

9848.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.31

0.35

2.4

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.37

0.34

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

303

2896

1.05

0.33

1.4

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

133

1243

1.07

0.32

1.3

1.4

mmol/l

7.2

7.0

0.24

904

(3006598) pH of Arterial cord blood

174

0.80

0.29

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.23

0.29

1.0

1.1

u/l

9.7

14.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

128

0.78

0.26

5.6

5.3

g/mol

27.9

443.4

—

116

(40765096) Chromosome analysis panel by Banding

187

1.18

0.26

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1008

0.93

0.26

1.6

mmol/l

7.6

0.04

616

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

213

2036

1.05

0.26

1.3

1.4

pmol/l

91.2

127.6

1.29

207

1984

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.26

0.26

1.3

46.0

57.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

424

1.11

0.26

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.25

1.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.32

0.23

1.2

1.5

nmol/l

42.9

21.0

—

(3033799) Differential panel - Peritoneal fluid

171

1.17

0.23

2.3

2.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

294

1.12

0.23

1.4

1.5

pmol/l

14.5

14.7

0.04

249

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.25

0.22

1.0

—

(44806071)

116

1.21

0.22

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

478

1.09

0.21

5.5

6.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

1.19

0.21

1.6

1.4

g/l

15.4

12.8

0.50

105

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.16

0.21

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.16

0.21

1.4

1.6

—

(3001556) Androgen free Index in Serum or Plasma

126

1.19

0.21

1.3

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

0.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

125.3

—

(3044007) Cell count panel - Peritoneal fluid

164

1.16

0.20

2.2

2.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.22

0.20

1.7

2.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

113

0.80

0.20

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.20

0.19

1.0

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.19

0.18

1.0

1.1

mg/l

13.9

10.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

166

1.14

0.18

2.4

2.5

—

(3026470) Cobalt [Mass/volume] in Blood

329

1.09

0.17

2.1

2.0

ug/l

1.4

3.5

3.97

290

(3000285) Sodium [Moles/volume] in Blood

1.22

0.17

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.11

0.17

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.75

0.17

2.8

2.3

u/field

1.8

0.6

—

(1761868) Lipid panel - Serum or Plasma

2736

27539

0.99

0.15

2.8

2.5

—

(3025577) Chromium [Mass/volume] in Blood

322

1.09

0.15

2.1

ug/l

1.4

2.6

2.48

275

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.10

0.15

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

171

0.88

0.14

1.5

49.4

61.8

—

142

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

150

0.87

0.14

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.17

0.13

6.7

6.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.17

0.13

7.2

8.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

144

1486

0.97

0.13

4.2

3.3

mg/l

22.2

26.1

0.74

902

(4281824)

797

1.04

0.11

1.1

—

(3035880) pH of Pleural fluid

259

1.08

0.11

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

342

0.94

0.10

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

144

1.11

0.10

2.4

4.4

u/l

74.6

70.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

368

1.06

0.10

1.1

1.0

ng/l

718.0

729.7

0.08

250

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.14

0.10

21.2

6.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

329

3339

0.98

0.09

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

126

1.11

0.09

1.2

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.83

0.08

1.2

1.4

66.4

73.8

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.81

0.08

1.0

g/l

166.4

163.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

371

1.05

0.08

1.1

1.0

ng/l

47.9

45.2

0.13

256

(1617658) Protocol used for examination of sentinel lymph nodes

590

1.03

0.07

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

377

0.95

0.07

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.05

0.07

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.02

0.07

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.12

0.06

7.5

2.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

183

0.93

0.06

2.6

1.9

e6/l

14239.2

16628.8

0.06

103

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

168

1.07

0.06

1.2

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

178

1.07

0.05

1.2

1.3

55.5

38.5

—

114

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

366

1.04

0.05

1.1

1.0

ng/l

323.8

333.9

0.08

257

(40758292) HTLV I+II Ab panel - Serum

130

1.08

0.04

1.4

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

298

1.04

0.04

2.3

2.4

nmol/l

166.5

151.1

0.35

255

(3021162) Amylase [Enzymatic activity/volume] in Specimen

119

0.92

0.03

4.3

3.2

u/l

531.4

3597.1

1.49

112

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

200

0.95

0.03

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

129

0.93

0.03

1.7

2.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

339

1.03

0.03

2.4

umol/l

51.8

52.2

0.03

290

(40768800) Prostate Pathology biopsy report

807

1.02

0.03

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

893

0.99

0.03

1.7

1.6

—

(4034850)

226

2246

1.01

0.02

10.1

8.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

162

1610

1.01

0.01

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

587

0.99

0.01

2.7

2.9

mg/l

46.7

58.7

0.24

431

(3023487) Leukocytes [#/volume] in Peritoneal fluid

204

1.03

0.00

2.4

2.2

e6/l

1560.9

979.9

0.28

149

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

233

0.99

0.00

2.2

2.5

ng/l

126.4

122.3

0.05

138

(3034092) Cytoplasmic Ig cells/100 cells in Blood

114

0.96

0.00

8.8

6.4

—

(4133840)

195

0.97

0.00

1.1

1.2

—

(3022689) Creatine [Moles/volume] in Urine

195

1.03

0.00

1.7

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

352

0.99

0.00

1.1

u/l

105.2

76.8

0.97

280

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

349

1.00

0.00

1.1

u/l

29.2

19.5

0.45

270

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

181

0.99

0.00

5.9

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

181

0.99

0.00

2.9

3.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.7

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.95

0.00

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.96

0.00

1.3

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.91

0.00

1.4

1.3

—

(4212803)

0.94

0.00

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

175

1750

1.00

0.00

1.3

ug/l

3.6

3.9

0.15

160

1593

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.01

0.00

1.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

2.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.94

0.00

1.2

3.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED – Adverse effects, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adverse effects, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adverse effects, not elsewhere classified (ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints